{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "import json\n",
    "import random"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "TRAIN = json.load(open(\"./training_data.txt\", 'r'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections. Recently, a new emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients in the Wuhan seafood market caused a major disease outbreak and has been named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes acute lung symptoms, leading to a condition that has been named as &ldquo;coronavirus disease 2019&rdquo; (COVID-19). The emergence of SARS-CoV-2 and of SARS-CoV caused widespread fear and concern and has threatened global health security. There are some similarities and differences in the epidemiology and clinical features between these two viruses and diseases that are caused by these viruses. The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms. Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals. CoV infections affect the respiratory, gastrointestinal, liver, and central nervous systems of humans, livestock, birds, bats, mice, and many other wild animals [1] [2] [3] . For example, severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012 were both coronaviruses that transmitted from animals to humans [4, 5] . The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and SARS-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients. It belongs to a new evolutionary branch within the CoV. On Feb. 11th, 2020, the new coronavirus was officially renamed \"SARS-CoV-2\" from \"2019-nCoV\" [6] . The disease caused by SARS-CoV-2 was called \"coronavirus disease 2019\" (COVID-19) [7] . According to  On Nov. 27th, 2002, a respiratory illness erupted in Guangdong Province, China [19] . In Feb, 2003, the Chinese Ministry of Health announced that this acute respiratory syndrome had thus far resulted in 305 cases and five deaths [20] . The following month, there were clusters of atypical pneumonia reported in other parts of mainland China, Hong Kong [21] , Canada [22] , and Singapore [23] . In Jul, 2003, SARS-CoV spread across 26 countries in six continents, and caused a cumulative 8,096 cases and 774 deaths (9.6%) [24] . In particular, a higher mortality (21%) was found in hospital personnel [25, 26] . On Dec. 29th, 2019, the health departments of Hubei Province received a report that four employees of the South China Seafood Wholesale Market were diagnosed with unknown-caused pneumonia in a local hospital, which was the first report of SARS-CoV-2 [27] . On Dec. 31st, 2019, the National Health Commission of People Republic of China and Chinese Center for Disease Control and Prevention (China CDC) participated in the investigation and case-searching work [27] . On the same day, the government of Wuhan released information about the disease outbreaks to society [28] . Nowadays, the number of patients infected with SARS-CoV-2 continues to climb worldwide. By the date of this paper\\'s submission, a cumulative 67,081 cases and 1,526 deaths (2.1%) were reported worldwide. In Wuhan, China, the number is 37,914. The main timeline of SARS and COVID-19 epidemic development were shown in Figure 1a ,b, respectively. Glucocorticoid and interferon Lopinavir/ritonavir (in testing) On Nov. 27th, 2002, a respiratory illness erupted in Guangdong Province, China [19] . In Feb, 2003, the Chinese Ministry of Health announced that this acute respiratory syndrome had thus far resulted in 305 cases and five deaths [20] . The following month, there were clusters of atypical pneumonia reported in other parts of mainland China, Hong Kong [21] , Canada [22] , and Singapore [23] . In Jul, 2003, SARS-CoV spread across 26 countries in six continents, and caused a cumulative 8,096 cases and 774 deaths (9.6%) [24] . In particular, a higher mortality (21%) was found in hospital personnel [25, 26] . On Dec. 29th, 2019, the health departments of Hubei Province received a report that four employees of the South China Seafood Wholesale Market were diagnosed with unknown-caused pneumonia in a local hospital, which was the first report of SARS-CoV-2 [27] . On Dec. 31st, 2019, the National Health Commission of People Republic of China and Chinese Center for Disease Control and Prevention (China CDC) participated in the investigation and case-searching work [27] . On the same day, the government of Wuhan released information about the disease outbreaks to society [28] . Nowadays, the number of patients infected with SARS-CoV-2 continues to climb worldwide. By the date of this paper\\'s submission, a cumulative 67,081 cases and 1,526 deaths (2.1%) were  The initial symptoms of SARS patients were fever (100%), cough (61.8%), myalgia (48.7%), dyspnea (40.8%), and diarrhea (31.6%) [29] , and the prognosis of patients was associated with host characteristics (including age, gender, etc.) [30] . During hospitalization, respiratory distress occurred in 90.8% of SARS patients [29] . The duration from disease onset to severe respiratory distress was an average of 9.8 ± 3.0 days [29] . During the disease course, some patients developed leukopenia, lymphopenia, and thrombocytopenia with an upregulation of aspartate transaminase (AST), alanine aminotransferase (ALT), lactic dehydrogenase (LDH), and C-reactive protein (CRP) [29] . In comparison, COVID-19 showed similar trends with SARS patients [28] . Fever, fatigue, and dry cough are the main manifestations of the patients, while nasal congestion, runny nose, and other symptoms of the upper respiratory tract are rare. Beijing Centers for Diseases Control and Prevention indicated that the typical case of COVID-19 has a progressive aggravation process. COVID-19 can be classified into light, normal, severe, and critical types based on the severity of the disease [31] : (1) Mild cases-the clinical symptoms were mild, and no pneumonia was found on the chest computed tomography (CT); (2) normal cases-fever, respiratory symptoms, and patients found to have imaging manifestations of pneumonia; (3) severe cases-one of the following three conditions: Respiratory distress, respiratory rate ≥ 30 times/min (in resting state, refers to oxygen saturation ≤ 93%), partial arterial oxygen pressure (PaO2)/oxygen absorption concentration (FiO2) ≤ 300 mmHg (1 mmHg = 0.133 kPa); (4) critical cases-one of the following three conditions: Respiratory failure and the need for mechanical ventilation, shock, or the associated failure of other organs requiring the intensive care unit [32] . The current clinical data shows that the majority of the deaths occurred in the older patients. However, severe cases have been documented in young adults who have unique factors, particularly those with chronic diseases, such as diabetes or hepatitis B. Those with a long-term use of hormones or immunosuppressants, and decreased immune function, are likely to get severely infected. The incubation period of SARS is 1-4 days [33] . However, in a small number of patients, the incubation period may be longer than 10 days [34] . It has been demonstrated that the latency of COVID-19 varies from 3-7 days on average, for up to 14 days [35] . During this incubation period, patients are contagious, and it has been reported that each case infected on average 3.77 other people (uncertainty range 2.23-4.82) [36] . By comparison, we found that the average latency of COVID-19 is slightly longer than that of SARS. According to the demographic information of SARS patients, infection occurred in all age groups (the average age was dyspnea (40.8%), and diarrhea (31.6%) [29] , and the prognosis of patients was associated with host characteristics (including age, gender, etc.) [30] . During hospitalization, respiratory distress occurred in 90.8% of SARS patients [29] . The duration from disease onset to severe respiratory distress was an average of 9.8 ± 3.0 days [29] . During the disease course, some patients developed leukopenia, lymphopenia, and thrombocytopenia with an upregulation of aspartate transaminase (AST), alanine aminotransferase (ALT), lactic dehydrogenase (LDH), and C-reactive protein (CRP) [29] . In comparison, COVID-19 showed similar trends with SARS patients [28] . Fever, fatigue, and dry cough are the main manifestations of the patients, while nasal congestion, runny nose, and other symptoms of the upper respiratory tract are rare. Beijing Centers for Diseases Control and Prevention indicated that the typical case of COVID-19 has a progressive aggravation process. COVID-19 can be classified into light, normal, severe, and critical types based on the severity of the disease [31] : (1) Mild cases-the clinical symptoms were mild, and no pneumonia was found on the chest computed tomography (CT); (2) normal cases-fever, respiratory symptoms, and patients found to have imaging manifestations of pneumonia; (3) severe cases-one of the following three conditions: Respiratory distress, respiratory rate ≥ 30 times / min (in resting state, refers to oxygen saturation ≤ 93%), partial arterial oxygen pressure (PaO2)/oxygen absorption concentration (FiO2) ≤ 300 mmHg (1 mmHg = 0.133 kPa); (4) critical cases-one of the following three conditions: Respiratory failure and the need for mechanical ventilation, shock, or the associated failure of other organs requiring the intensive care unit [32] . The current clinical data shows that the majority of the deaths occurred in the older patients. However, severe cases have been documented in young adults who have unique factors, particularly those with chronic diseases, such as diabetes or hepatitis B. Those with a long-term use of hormones or immunosuppressants, and decreased immune function, are likely to get severely infected. The incubation period of SARS is 1-4 days [33] . However, in a small number of patients, the incubation period may be longer than 10 days [34] . It has been demonstrated that the latency of COVID-19 varies from 3-7 days on average, for up to 14 days [35] . During this incubation period, patients are contagious, and it has been reported that each case infected on average 3.77 other people (uncertainty range 2.23-4.82) [36] . By comparison, we found that the average latency of COVID-19 is slightly longer than that of SARS. According to the demographic information of SARS patients, infection occurred in all age groups (the average age was ≦45) [37] . There was a proportional difference between male and female (female predominance) [37] , with a male-to-female ratio of 1:1.25 [38] . In addition, hospital staff had a higher risk due to the proximal interactions with large numbers from the infected population. For example, hospital staff accounted for 22% of all cases in Hong Kong and 22.8% in Guangdong [37] . The mortality caused by SARS increased with age (> 64 years) [37] , and the overall mortality rate during the outbreak of SARS was estimated at 9.6% [39, 40] . Li et al. reported that people who have not been exposed to SARS-CoV-2 are all susceptible to COVID-19 [41] . Among the 8,866 patients who have been confirmed with COVID-19, nearly half of the patients have been aged 50 years or older (47.7%) [36] . The male-to-female ratio is about 2.7:1 [38] and the average incubation period is 5.2 days [42] . However, severe COVID-19 cases and deaths have mostly been in the middle-aged adults and the elderly with long smoking histories or other 45) [37] . There was a proportional difference between male and female (female predominance) [37] , with a male-to-female ratio of 1:1.25 [38] . In addition, hospital staff had a higher risk due to the proximal interactions with large numbers from the infected population. For example, hospital staff accounted for 22% of all cases in Hong Kong and 22.8% in Guangdong [37] . The mortality caused by SARS increased with age (> 64 years) [37] , and the overall mortality rate during the outbreak of SARS was estimated at 9.6% [39, 40] . Li et al. reported that people who have not been exposed to SARS-CoV-2 are all susceptible to COVID-19 [41] . Among the 8,866 patients who have been confirmed with COVID-19, nearly half of the patients have been aged 50 years or older (47.7%) [36] . The male-to-female ratio is about 2.7:1 [38] and the average incubation period is 5.2 days [42] . However, severe COVID-19 cases and deaths have mostly been in the middle-aged adults and the elderly with long smoking histories or other basic diseases, such as heart disease and hypertension [43, 44] . At the time that this paper was been submitted, COVID-19 patients mortality rate was 2.1% [45] . In 2010, Shi et al. isolated a SARS-like coronavirus which was highly homologous to the SARS-CoV, confirming that Rhinolophus sinicus (Chinese rufous horseshoe bat) was a natural host of the SARS-CoV [46] . Bats are known to be hosts for 30 coronaviruses based on complete genomic sequences analysis [47] . Epidemiological investigations have shown that civet cats in the wildlife market were the direct source of SARS-CoV [48] . Among the four patients with SARS discovered during the winter of 2003-2004, two were waitresses at a restaurant in Guangzhou, China, and one was a customer who Viruses 2020, 12, 244 5 of 17 ate in the restaurant a short distance from a civet cage. All six civets in this cage were tested positive for SARS-CoV [48] . The new emerging SARS-CoV-2 shares about 80% of the gene sequence of SARS-CoV, released by the Military Medical Research Institute of Nanjing Military Region in 2003 [28] . Recently, Shi et al. reported that the sequence similarity of coronavirus between SARS-CoV-2 and the coronavirus isolated from Rhinolophus affinis is 96.2%, and suggested that bats may be the source of the virus [49] . So far, the intermediate hosts of SARS-CoV-2 are elusive and have been reported to be snakes, minks, or variable others [50, 51] . Recently, a research group of South China Agricultural University reported that pangolins may be one of the intermediate hosts for SARS-CoV-2, by analyzing more than 1,000 metagenomic samples, because they found that 70% of pangolins are positive for the coronavirus. Moreover, the virus isolate from pangolin shared 99% sequence similarity with the current infected human strain SARS-CoV-2 [52] . Taking this recent research into consideration, we agreed that pangolin is more likely to be one of intermediate hosts of SARS-CoV-2. According to the WHO data on Jul. 31th, 2003 [24] , a total of 8,096 clinically diagnosed cases of SARS were reported worldwide, with 774 deaths and 26 countries and regions affected (Figure 2a ). Most cases were in Asia, Europe, and America. The main countries in Asia were China (including mainland, Macao, Hong Kong, and Taiwan), Singapore, and so on. The total number of cases in mainland China was 5,327, with 349 deaths [53] . The cases were mainly concentrated in Beijing, Guangdong, and Shanxi ( Figure 2b ) [54] . In total, 2,102 patients were from Hong Kong, Macao, and Taiwan, with 336 deaths [24] . Viruses 2020, 12, x FOR PEER REVIEW 5 of 18 basic diseases, such as heart disease and hypertension [43, 44] . At the time that this paper was been submitted, COVID-19 patients mortality rate was 2.1% [45] . In 2010, Shi et al. isolated a SARS-like coronavirus which was highly homologous to the SARS-CoV, confirming that Rhinolophus sinicus (Chinese rufous horseshoe bat) was a natural host of the SARS-CoV [46] . Bats are known to be hosts for 30 coronaviruses based on complete genomic sequences analysis [47] . Epidemiological investigations have shown that civet cats in the wildlife market were the direct source of SARS-CoV [48] . Among the four patients with SARS discovered during the winter of 2003-2004, two were waitresses at a restaurant in Guangzhou, China, and one was a customer who ate in the restaurant a short distance from a civet cage. All six civets in this cage were tested positive for SARS-CoV [48] . The new emerging SARS-CoV-2 shares about 80% of the gene sequence of SARS-CoV, released by the Military Medical Research Institute of Nanjing Military Region in 2003 [28] . Recently, Shi et al. reported that the sequence similarity of coronavirus between SARS-CoV-2 and the coronavirus isolated from Rhinolophus affinis is 96.2%, and suggested that bats may be the source of the virus [49] . So far, the intermediate hosts of SARS-CoV-2 are elusive and have been reported to be snakes, minks, or variable others [50, 51] . Recently, a research group of South China Agricultural University reported that pangolins may be one of the intermediate hosts for SARS-CoV-2, by analyzing more than 1,000 metagenomic samples, because they found that 70% of pangolins are positive for the coronavirus. Moreover, the virus isolate from pangolin shared 99% sequence similarity with the current infected human strain SARS-CoV-2 [52] . Taking this recent research into consideration, we agreed that pangolin is more likely to be one of intermediate hosts of SARS-CoV-2. According to the latest data on Feb. 14th, 2020 [55, 56] , there have been a total of 67,081 clinically diagnosed cases of COVID-19 in worldwide, with 1,526 deaths. A total of 25 countries and regions have infected people. Due to the Spring Festival transportation peak, the disease has been spread more rapidly across China (Figure 2c ). As the origin area of COVID-19, Hubei province has been the most severely infected area, with 54,406 cumulative diagnosis cases. Wuhan city has 37,914 cases. Guangdong, Henan, and Zhejiang province have 1,294 cases, 1,212 cases, and 1,162 cases, respectively (Figure 2d ). At present, the COVID-19 outbreak has been spread to all parts of China and around the world, including the United States, Thailand, and Japan. It has been noticed that most of these patients have ever been to Wuhan or contacted with people who had been in Wuhan. The distribution of COVID-2019 patients in China (including Hong Kong, Macao and Taiwan) and Hubei Province is shown in Figure 3 . SARS were reported worldwide, with 774 deaths and 26 countries and regions affected (Figure 2a) . Most cases were in Asia, Europe, and America. The main countries in Asia were China (including mainland, Macao, Hong Kong, and Taiwan), Singapore, and so on. The total number of cases in mainland China was 5,327, with 349 deaths [53] . The cases were mainly concentrated in Beijing, Guangdong, and Shanxi (Figure 2b ) [54] . In total, 2,102 patients were from Hong Kong, Macao, and Taiwan, with 336 deaths [24] . According to the latest data on Feb. 14th, 2020 [55, 56] , there have been a total of 67,081 clinically diagnosed cases of COVID-19 in worldwide, with 1,526 deaths. A total of 25 countries and regions have infected people. Due to the Spring Festival transportation peak, the disease has been spread more rapidly across China (Figure 2c ). As the origin area of COVID-19, Hubei province has been the most severely infected area, with 54,406 cumulative diagnosis cases. Wuhan city has 37,914 cases. Guangdong, Henan, and Zhejiang province have 1,294 cases, 1,212 cases, and 1,162 cases, respectively (Figure 2d ). At present, the COVID-19 outbreak has been spread to all parts of China and around the world, including the United States, Thailand, and Japan. It has been noticed that most of these patients have ever been to Wuhan or contacted with people who had been in Wuhan. The distribution of COVID-2019 patients in China (including Hong Kong, Macao and Taiwan) and Hubei Province is shown in Figure 3 .  As the number of COVID-19 patients in China has been growing rapidly, preventing the spread of SARS-CoV-2 is the most important and urgent task [57] . It was shown that human-to-human transmission of SARS-CoV-2 has spread via droplets or close contacts [58, 59] , but aerosol and fecal-oral transmission still need further study [60, 61] . To reduce virus transmission, early detection and isolation are essential. In addition, close monitoring in crowded places is also important [62] . The possible pathogens of SARS and COVID-19 are both derived from wild animals [63] . Therefore, hunting, selling, and eating wild animals not only seriously damage the ecosystem, but also lead to the spread of epidemic diseases [64] . Thus, banning all wildlife trade is an effective measure to prevent viral prevalence. Wearing level-D protective clothing can protect medical staff from infection of respiratory viruses [65] . A vaccine against SARS-CoV has not been described in any published articles [66] . However, on Jan. 26th, 2020, the China CDC started to develop a new vaccine for SARS-CoV-2. The virus has been successfully isolated and seed strains have been screened [67] . The early symptoms of SARS and COVID-19 are very similar to winter influenza, and the most important way to distinguish flu and pneumonia is to take throat swabs for viral testing [68] . Current diagnostic tests for coronavirus include RT-PCR, real-time reverse transcription PCR (rRT-PCR), reverse transcription loop-mediated isothermal amplification, as well as real-time RT-LAMP [69] [70] [71] [72] . National Medical Products Administration has approved seven new nucleic acid test reagents for coronavirus, which were developed based on fluorescence PCR by Feb. 1st, 2020 [73] . Suspected infections can be detected accurately and quickly for timely isolation and treatment to avoid infecting others by using these test reagents. Both SARS-CoV and SARS-CoV-2 are CoVs; hence, the treatment strategies of SARS could be relevant for COVID-19 [74] . In 2003, SARS was mainly treated by isolation of the patients, hormones treatment, antiviral and symptomatic treatments, and many drugs such as glucocorticoid [29] and interferon [75] . Now, isolation, antiviral, and symptomatic treatments are still mainly adopted for COVID-19 treatment. As effective drugs for SARS, hormones and interferons can also be used to treat COVID-19 [74] . Lopinavir is one kind of protease inhibitor used to treat HIV infection, with ritonavir as a booster. Lopinavir and/or ritonavir has anti coronavirus activity in vitro. Hong Kong scholars found that, compared with ribavirin alone, patients treated with lopinavir/ritonavir and ribavirin had lower risk of acute respiratory distress syndrome (ARDS) or death caused by SARS-CoV [76, 77] . Lopinavir/ritonavir has also been clinically tested in treatment of COVID-19, and showed wonderfully effective treatment for some patients, but the general clinical effect has not been determined [78] . More effective treatments are still under continuing exploration: On Jan. 25th, 2020, a joint research team from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Shanghai Tech University screened and identified 30 potential drugs that are reported to be effective against SARS-CoV-2 [79] . A high-resolution crystal structure of SARS-CoV-2 coronavirus 3CL hydrolase (Mpro) was announced after the outbreak of COVID-19 in the world [80] , and human coronaviruses (HCoVs) have been treated as severe pathogens in respiratory tract infections. Nelfinavir was predicted to be a potential inhibitor of SARS-CoV-2 main protease [81] . The first patient in the US had been trial-treated with intravenous remdesivir (a novel nucleotide analogue prodrug in development) due to a severe infection [82, 83] . No adverse reactions were observed during the administration, and the patient\\'s condition was effectively improved [84] . Clinical trials of remdesivir for treatment of COVID-19 just started on Feb. 5th and 12th, 2020 in Wuhan and Beijing, respectively, and the experimental results remain unclear [85, 86] . CoVs are RNA viruses and contain the largest genomes of all RNA viruses [87] . CoVs belong to the subfamily Coronavirinae in the family of Coronaviridae of the order Nidovirales, and this subfamily includes four genera: α-coronavirus, β-coronavirus, γ-coronavirus, and δ-coronavirus [88] . Both SARS-CoV-2 and SARS-CoV are in the coronavirus family, β-coronavirus genera [89] . The genome of SARS-CoV-2 is more than 85% similar to the genome of the SARS-like virus ZC45 (bat-SL-CoVZC45, MG772933.1), and together these types of viruses form a unique Orthocoronavirinae subfamily with another SARS-like virus ZXC21 in the sarbecovirus subgenus [35] . All the three viruses show typical β-coronavirus gene structure. Human SARS-CoV and a genetically similar bat coronavirus (bat-SL-CoVZXC21, MG772934) from southwest of China have formed another clade within the sarbecovirus [35] . We also performed comparative genomic analyses of SARS-CoV-2 and SARS-CoV by zpicture. The results showed that the genomic sequences of SARS-CoV-2 and SARS-CoV have extremely high homology at the nucleotide level (Figure 4a,b) . There are six regions of difference (RD) in the genome sequence between SARS-CoV and SARS-CoV-2, and the RDs are named according to the order of discovery. RD1, RD2, and RD3 (448nt, 55nt, and 278nt, respectively) are partial coding sequences of the orf lab gene; RD4 and RD5 (315nt and 80nt, respectively) are partial coding sequences of the S gene; RD6 is 214nt in size and is part of the coding sequence of the orf7b and orf8 genes. These RDs may sequences of the orf lab gene; RD4 and RD5 (315nt and 80nt, respectively) are partial coding sequences of the S gene; RD6 is 214nt in size and is part of the coding sequence of the orf7b and orf8 genes. These RDs may provide new molecular markers for the identification of SARS-CoV-2 and SARS-CoV, and also help to develop new drugs against SARS-CoV-2. To analyze the homogeneity of SARS-CoV, MERS-CoV, and SARS-CoV-2, an evolutionary tree was constructed based on the genomes of 35 SARS-CoV-2 strains from different data submission units, one SARS-CoV strain, and two MERS-CoV strains ( Figure S1 ). Phylogenetic analysis showed that the distance of SARS-CoV (AY274119) is closer to SARS-CoV-2 strains than MERS-CoV (KC164505, JX869059). To analyze the homogeneity of SARS-CoV, MERS-CoV, and SARS-CoV-2, an evolutionary tree was constructed based on the genomes of 35 SARS-CoV-2 strains from different data submission units, one SARS-CoV strain, and two MERS-CoV strains ( Figure S1 ). Phylogenetic analysis showed that the distance of SARS-CoV (AY274119) is closer to SARS-CoV-2 strains than MERS-CoV (KC164505, JX869059). To further explore whether all encoded proteins of SARS-CoV-2 are homologous to that of SARS-CoV, we performed a protein sequence alignment analysis using Blastp. The results showed that most of SARS-CoV-2 proteins are highly homologous (95%-100%) to the proteins of SARS-CoV virus, indicating the evolutionary similarity between SARS-CoV and SARS-CoV-2 (Table 2) . However, two proteins (orf8 and orf10) in SARS-CoV-2 have no homologous proteins in SARS-CoV. The amino acid sequence of orf8 in SARS-CoV-2 is different from sequences of conserved orf8 or orf8b derived from human SARS-CoV [11] . Orf8 protein of SARS-CoV-2 does not contain known functional domain or motif. An aggregation motif VLVVL (amino acid 75-79) has been found in SARS-CoV orf8b which was shown to trigger intracellular stress pathways and activate NOD-like receptor family pyrin domain-containing-3 (NLRP3) inflammasomes [90] . Therefore, it will be clinically meaningful to analyze the biological function of these two specific proteins (orf8 and orf10) in SARS-CoV-2. As the most abundant protein in CoVs, nucleocapsid (N) protein is highly conserved across CoVs [91] . The N protein in SARS-CoV-2 shares~90% amino acid identity with that in SARS-CoV [28] , which indicates that antibodies against the N protein of SARS-CoV would likely recognize and bind the N protein of SARS-CoV-2 as well. N antibodies do not provide immunity to SARS-CoV-2 infection, but the antibodies have a cross reactivity with SARS-CoV N protein viruses, which would allow a serum-based assay to identify the asymptomatic SARS-CoV-2 infected-cases [28] . Although previous studies have found serum reactivity to group SARS-CoV N proteins in Chinese populations [92] , exposure to SARS-CoV-2 should increase the dilution factor if the infection had occurred. This information has important implications for preventing the spread of asymptomatic infections. In addition, spike stalk S2 in SARS-CoV-2 is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs (bat-SL-CoVZXC21 and bat-SL-CoVZC45) and human SARS-CoV [11] . Thus, the broad spectrum antiviral peptides against S2 has the potential to be effective treatment [93] . Many studies have been performed to study the pathogenesis of SARS-CoV [94] [95] [96] . The spike (S) protein and N protein confer stability to the viral particle [97] . The N protein is a structural protein involved in virion assembly, and plays a pivotal role in virus transcription and assembly efficiency [97] . S protein can bind to the cellular receptors of sensitive cells and mediate infection of their target cells, after which it begins to replicate in the cytoplasm [98] . SARS-CoV mainly targets the lungs, immune organs, and small systemic blood vessels and causes systemic vasculitis and decrease of immune function [99] . More seriously, the infection leads to extensive pulmonary consolidation, diffuse alveolar damage, and the formation of a transparent membrane, finally deteriorating to respiratory distress [100] . CoV can enter host cells through the interaction between CoV S protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which is isolated from SARS-CoV-permissive Vero-E6 cells. The receptor-binding motif (RBM) of S protein can directly contact ACE2 [47, 101, 102] . AEC2 have been identified to be key binding residues and functional receptor for SARS-CoV, and it can also protect alveolar cells [103] . The binding of spike protein to ACE2 and the subsequent downregulation of this receptor contribute to severe alveolar injury during SARS [49] . The downregulation of ACE2 results in the excessive production of angiotensin II by the related enzyme ACE, and the stimulation of type 1A angiotensin II receptor (AGTR1A) can lead to the increase of pulmonary vascular permeability, which potentially explains the increased lung pathology when the expression of ACE2 is decreased [104] . ACE2-transfected T cells form multinucleated syncytia with cells expressing S protein. The virus was shown to replicate effectively in ACE2-transfected, but not in mock-transfected T cells. Antibodies targeting ACE2 can block viral replication in Vero-E6 cells [105] . Recently, Ji et al. demonstrated that the receptor binding domain of SARS-CoV-2 was capable of binding ACE2 in the context of the SARS-CoV spike protein [51] . Among SRAS-CoV spike protein\\'s fourteen residues predicted to interact directly with human ACE2 as the receptor for SARS-CoV, eight amino acids are well conserved in homology SARS-CoV-2 spike protein [26, 102] . At the same time, Wan et al. showed that SARS-CoV-2 uses ACE2 receptors to infect humans, bats, civets, monkeys, and swine, but not mice [106] . Compared to previously reported SARS-CoV strains, SARS-CoV-2 uses ACE2 receptors more efficiently than human SARS-CoV (year 2003), but less efficiently than human SARS-CoV (year 2002) [106] . The mutation of proteins determines two important characteristics of the SARS-CoV-2: A higher ability to infect and enhanced pathogenicity than the bat-like SARS-CoV, but a lower pathogenicity than SARS-CoV [43] . As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent. On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [55] . Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [74] . Although it was reported that the clinically recovered patients exceed the number of dead, the majority of the patients are still not cured in hospital. In addition, the potential adaptive mutation of SARS-CoV-2 makes it difficult for vaccine development. Therefore, it is urgent for us to develop more sensitive inspection methods and effective drugs. Seven type of CoVs have been identified to cause human disease [107] . The two highly pathogenic viruses, SARS-CoV and MERS-CoV, cause severe respiratory syndrome in humans. The other four human CoVs (HCoV-NL63, HCoV-229E, HCoV-OC43 and HKU1) induce only mild upper respiratory diseases, although some of them can cause severe infections in infants, young children, and elderly individuals [4, 108] . The latest one is SARS-CoV-2. It has been reported that SARS-CoV-2 shared almost 80% of the genome with SARS-CoV [11] . Our results also showed that almost all encoded proteins of SARS-CoV-2 are homologous to SARS-CoV proteins ( Table 2) . Hence, clinical drugs and therapies for treating SARS may be used as a reference for COVID-19 treatment [74] . In addition to the well-known SARS-CoV, MERS-CoV, as one Merbecovirus subgenus of β-CoVs, is also extremely invasive. MERS-CoV is the pathogen of the Middle East Respiratory Syndrome, which can infect both humans and animals, and can be transmitted through camels [109] . It mainly occurs in Saudi Arabia and has a high mortality rate [66] . Studies had demonstrated that the clinical course of SARS and MERS was highly similar, and SARS and MERS may have similar pathogenesis [66] . The genome sequence of SARS-CoV-2 also shows some similarities to that of MERS-CoV. It will be very interesting to study the relationship among SARS-CoV, MERS-CoV, and SARS-CoV-2 that may be exploited for future developing broad-spectrum antiviral therapies. Although more and more studies for SARS-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3 ). In-depth understanding the underlying pathogenic mechanisms of SARS-CoV-2 will reveal more targets for better therapy of COVID-19. Table 3 . Proposed questions to study SARS-CoV-2 for future studies. What is the effect of the surface epitope and receptor binding domain of S protein of SARS-CoV-2 on the virus\\' infectivity? Is there any effect of SARS-CoV vaccine designed according to S protein on SARS-CoV-2? Does SARS-CoV-2 orf8 and orf10 proteins, which have no homology proteins in SARS-CoV, play roles in the infectivity and pathogenicity of SARS-CoV-2? Can the susceptibility of asymptomatic carriers be judged by detecting the serum reactivity level of N protein? Apart from droplet transmission and contact transmission, are there other methods to transmit SARS-CoV-2? What is the percentage of COVID-19 patients have been infected with SARS and produced antibodies? Is there an effective specific anti-SARS-CoV-2 solution? Does traditional Chinese medicine have any effect on the treatment of COVID-19 caused by SARS-CoV-2? Do ethnic differences affect the transmissibility and pathogenicity of SARS-CoV-2? Do any environmental factors, such as regional conditions or climate, affect SARS-CoV-2 transmission? Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/2/244/s1, Figure S1 : Phylogeny of SARS-CoV-2, SARS-CoV and MERS-CoV. Unrooted phylogenetic relationships are represented by constructing Neighbor-Joining tree. Table S1 : The genomic information of latest SARS-CoV-2 strains Author Contributions: Conceptualization, L.X., Y.W. and X.G.; methodology, J.X. and W.Z.; software, S.Z. and W.Z.; validation, J.X., S.Z. and T.T.; formal analysis, J.X. and S.Z.; writing-original draft preparation, J.X. and S.Z.; writing-review and editing, L.X., Y.W., W.Z. and X.G.; visualization, J.X., S.Z., and A.E.A.; funding acquisition, L.X., Y.W. and X.G. All authors have read and agreed to the published version of the manuscript.  ',\n",
       " {'entities': [[25, 28, 'CARDINAL'],\n",
       "   [39, 44, 'ORGANISM'],\n",
       "   [63, 76, 'CORONAVIRUS'],\n",
       "   [78, 88, 'CORONAVIRUS'],\n",
       "   [93, 97, 'CORONAVIRUS'],\n",
       "   [98, 101, 'CORONAVIRUS'],\n",
       "   [163, 167, 'CORONAVIRUS'],\n",
       "   [185, 189, 'DATE'],\n",
       "   [197, 210, 'CORONAVIRUS'],\n",
       "   [212, 217, 'CORONAVIRUS'],\n",
       "   [262, 277, 'ORG'],\n",
       "   [281, 309, 'CHEMICAL'],\n",
       "   [335, 339, 'CORONAVIRUS'],\n",
       "   [358, 380, 'CHEMICAL'],\n",
       "   [384, 405, 'CHEMICAL'],\n",
       "   [422, 427, 'GPE'],\n",
       "   [498, 543, 'CORONAVIRUS'],\n",
       "   [547, 557, 'CORONAVIRUS'],\n",
       "   [652, 663, 'CORONAVIRUS'],\n",
       "   [672, 676, 'DATE'],\n",
       "   [677, 682, 'GPE'],\n",
       "   [685, 693, 'CORONAVIRUS'],\n",
       "   [713, 723, 'CORONAVIRUS'],\n",
       "   [731, 735, 'CORONAVIRUS'],\n",
       "   [736, 739, 'CORONAVIRUS'],\n",
       "   [794, 807, 'CHEMICAL'],\n",
       "   [918, 921, 'CARDINAL'],\n",
       "   [1047, 1051, 'CORONAVIRUS'],\n",
       "   [1052, 1055, 'CORONAVIRUS'],\n",
       "   [1060, 1070, 'CORONAVIRUS'],\n",
       "   [1220, 1233, 'CORONAVIRUS'],\n",
       "   [1235, 1239, 'CORONAVIRUS'],\n",
       "   [1307, 1314, 'CHEMICAL'],\n",
       "   [1316, 1319, 'CORONAVIRUS'],\n",
       "   [1419, 1428, 'ORGANISM'],\n",
       "   [1437, 1441, 'WILDLIFE'],\n",
       "   [1443, 1447, 'ORGANISM'],\n",
       "   [1464, 1476, 'WILDLIFE'],\n",
       "   [1539, 1543, 'CORONAVIRUS'],\n",
       "   [1548, 1552, 'DATE'],\n",
       "   [1595, 1599, 'CORONAVIRUS'],\n",
       "   [1604, 1608, 'DATE'],\n",
       "   [1619, 1632, 'CORONAVIRUS'],\n",
       "   [1655, 1662, 'CHEMICAL'],\n",
       "   [1696, 1717, 'CHEMICAL'],\n",
       "   [1742, 1747, 'GPE'],\n",
       "   [1766, 1776, 'CORONAVIRUS'],\n",
       "   [1784, 1795, 'CORONAVIRUS'],\n",
       "   [1819, 1841, 'CHEMICAL'],\n",
       "   [1906, 1909, 'CORONAVIRUS'],\n",
       "   [1919, 1929, 'DATE'],\n",
       "   [1939, 1950, 'CORONAVIRUS'],\n",
       "   [1975, 1985, 'CORONAVIRUS'],\n",
       "   [1993, 2002, 'CORONAVIRUS'],\n",
       "   [2032, 2042, 'CORONAVIRUS'],\n",
       "   [2055, 2066, 'CORONAVIRUS'],\n",
       "   [2075, 2079, 'DATE'],\n",
       "   [2082, 2090, 'CORONAVIRUS'],\n",
       "   [2093, 2094, 'DATE'],\n",
       "   [2115, 2118, 'DATE'],\n",
       "   [2120, 2130, 'DATE'],\n",
       "   [2165, 2183, 'GPE'],\n",
       "   [2185, 2190, 'GPE'],\n",
       "   [2216, 2223, 'NORP'],\n",
       "   [2224, 2242, 'CHEMICAL'],\n",
       "   [2315, 2318, 'CARDINAL'],\n",
       "   [2329, 2333, 'CARDINAL'],\n",
       "   [2348, 2367, 'DATE'],\n",
       "   [2438, 2452, 'GPE'],\n",
       "   [2489, 2498, 'GPE'],\n",
       "   [2509, 2512, 'GPE'],\n",
       "   [2514, 2518, 'DATE'],\n",
       "   [2520, 2524, 'CORONAVIRUS'],\n",
       "   [2525, 2528, 'CORONAVIRUS'],\n",
       "   [2559, 2562, 'CARDINAL'],\n",
       "   [2615, 2618, 'CARDINAL'],\n",
       "   [2726, 2729, 'TISSUE'],\n",
       "   [2731, 2741, 'DATE'],\n",
       "   [2807, 2811, 'CARDINAL'],\n",
       "   [2946, 2951, 'ORDINAL'],\n",
       "   [2962, 2972, 'CORONAVIRUS'],\n",
       "   [2974, 2976, 'DATE'],\n",
       "   [2983, 2986, 'TISSUE'],\n",
       "   [2988, 2998, 'DATE'],\n",
       "   [3034, 3040, 'ORGANISM'],\n",
       "   [3053, 3058, 'CELL'],\n",
       "   [3063, 3070, 'NORP'],\n",
       "   [3071, 3097, 'CHEMICAL'],\n",
       "   [3193, 3205, 'DATE'],\n",
       "   [3225, 3230, 'GPE'],\n",
       "   [3345, 3355, 'CORONAVIRUS'],\n",
       "   [3458, 3461, 'CARDINAL'],\n",
       "   [3504, 3509, 'GPE'],\n",
       "   [3511, 3516, 'CELL'],\n",
       "   [3532, 3534, 'DATE'],\n",
       "   [3535, 3538, 'CARDINAL'],\n",
       "   [3561, 3565, 'CORONAVIRUS'],\n",
       "   [3570, 3578, 'CORONAVIRUS'],\n",
       "   [3614, 3623, 'CHEMICAL'],\n",
       "   [3642, 3656, 'CHEMICAL'],\n",
       "   [3708, 3711, 'DATE'],\n",
       "   [3713, 3723, 'DATE'],\n",
       "   [3758, 3776, 'GPE'],\n",
       "   [3778, 3783, 'GPE'],\n",
       "   [3809, 3816, 'NORP'],\n",
       "   [3817, 3835, 'CHEMICAL'],\n",
       "   [3908, 3911, 'CARDINAL'],\n",
       "   [3922, 3926, 'CARDINAL'],\n",
       "   [3941, 3960, 'DATE'],\n",
       "   [4031, 4045, 'GPE'],\n",
       "   [4082, 4091, 'GPE'],\n",
       "   [4102, 4105, 'GPE'],\n",
       "   [4107, 4111, 'DATE'],\n",
       "   [4113, 4117, 'CORONAVIRUS'],\n",
       "   [4118, 4121, 'CORONAVIRUS'],\n",
       "   [4152, 4155, 'CARDINAL'],\n",
       "   [4208, 4211, 'CARDINAL'],\n",
       "   [4319, 4322, 'TISSUE'],\n",
       "   [4324, 4334, 'DATE'],\n",
       "   [4400, 4404, 'CARDINAL'],\n",
       "   [4539, 4544, 'ORDINAL'],\n",
       "   [4555, 4565, 'CORONAVIRUS'],\n",
       "   [4567, 4569, 'DATE'],\n",
       "   [4576, 4579, 'TISSUE'],\n",
       "   [4581, 4591, 'DATE'],\n",
       "   [4627, 4633, 'ORGANISM'],\n",
       "   [4646, 4651, 'CELL'],\n",
       "   [4656, 4663, 'NORP'],\n",
       "   [4664, 4690, 'CHEMICAL'],\n",
       "   [4786, 4798, 'DATE'],\n",
       "   [4818, 4823, 'GPE'],\n",
       "   [4938, 4948, 'CORONAVIRUS'],\n",
       "   [5051, 5054, 'CARDINAL'],\n",
       "   [5099, 5103, 'CORONAVIRUS'],\n",
       "   [5125, 5128, 'CARDINAL'],\n",
       "   [5195, 5197, 'DATE'],\n",
       "   [5383, 5387, 'CORONAVIRUS'],\n",
       "   [5439, 5466, 'CHEMICAL'],\n",
       "   [5485, 5488, 'CARDINAL'],\n",
       "   [5491, 5503, 'DATE'],\n",
       "   [5658, 5665, 'CHEMICAL'],\n",
       "   [5769, 5777, 'CORONAVIRUS'],\n",
       "   [5785, 5799, 'CARDINAL'],\n",
       "   [5805, 5809, 'CORONAVIRUS'],\n",
       "   [5846, 5855, 'ORG'],\n",
       "   [5969, 5986, 'CHEMICAL'],\n",
       "   [5997, 6004, 'GPE'],\n",
       "   [6084, 6092, 'CORONAVIRUS'],\n",
       "   [6132, 6140, 'CORONAVIRUS'],\n",
       "   [6244, 6246, 'DATE'],\n",
       "   [6332, 6357, 'CHEMICAL'],\n",
       "   [6491, 6494, 'CARDINAL'],\n",
       "   [6512, 6517, 'CARDINAL'],\n",
       "   [6647, 6662, 'CHEMICAL'],\n",
       "   [6679, 6685, 'CHEMICAL'],\n",
       "   [6720, 6728, 'QUANTITY'],\n",
       "   [6741, 6744, 'CARDINAL'],\n",
       "   [6770, 6773, 'CARDINAL'],\n",
       "   [6791, 6796, 'CARDINAL'],\n",
       "   [6929, 6956, 'EVENT'],\n",
       "   [6972, 6985, 'ORG'],\n",
       "   [7245, 7253, 'CHEMICAL'],\n",
       "   [7257, 7275, 'CHEMICAL'],\n",
       "   [7370, 7374, 'CORONAVIRUS'],\n",
       "   [7378, 7390, 'DATE'],\n",
       "   [7438, 7455, 'CHEMICAL'],\n",
       "   [7463, 7486, 'DATE'],\n",
       "   [7535, 7543, 'CORONAVIRUS'],\n",
       "   [7556, 7564, 'DATE'],\n",
       "   [7581, 7598, 'DATE'],\n",
       "   [7729, 7735, 'ORGANISM'],\n",
       "   [7757, 7761, 'DATE'],\n",
       "   [7767, 7769, 'DATE'],\n",
       "   [7825, 7833, 'CORONAVIRUS'],\n",
       "   [7866, 7870, 'CORONAVIRUS'],\n",
       "   [7916, 7920, 'CORONAVIRUS'],\n",
       "   [8020, 8022, 'DATE'],\n",
       "   [8208, 8212, 'CORONAVIRUS'],\n",
       "   [8264, 8291, 'CHEMICAL'],\n",
       "   [8310, 8313, 'CARDINAL'],\n",
       "   [8316, 8328, 'DATE'],\n",
       "   [8483, 8490, 'CHEMICAL'],\n",
       "   [8594, 8602, 'CORONAVIRUS'],\n",
       "   [8610, 8624, 'CARDINAL'],\n",
       "   [8630, 8634, 'CORONAVIRUS'],\n",
       "   [8671, 8680, 'ORG'],\n",
       "   [8794, 8811, 'CHEMICAL'],\n",
       "   [8822, 8829, 'GPE'],\n",
       "   [8909, 8917, 'CORONAVIRUS'],\n",
       "   [8957, 8965, 'CORONAVIRUS'],\n",
       "   [9069, 9071, 'DATE'],\n",
       "   [9157, 9182, 'CHEMICAL'],\n",
       "   [9316, 9319, 'CARDINAL'],\n",
       "   [9337, 9342, 'CARDINAL'],\n",
       "   [9474, 9489, 'CHEMICAL'],\n",
       "   [9506, 9512, 'CHEMICAL'],\n",
       "   [9547, 9555, 'QUANTITY'],\n",
       "   [9568, 9571, 'CARDINAL'],\n",
       "   [9597, 9600, 'CARDINAL'],\n",
       "   [9618, 9623, 'CARDINAL'],\n",
       "   [9756, 9783, 'EVENT'],\n",
       "   [9799, 9812, 'ORG'],\n",
       "   [10072, 10080, 'CHEMICAL'],\n",
       "   [10084, 10102, 'CHEMICAL'],\n",
       "   [10197, 10201, 'CORONAVIRUS'],\n",
       "   [10205, 10217, 'DATE'],\n",
       "   [10265, 10282, 'CHEMICAL'],\n",
       "   [10290, 10313, 'DATE'],\n",
       "   [10362, 10370, 'CORONAVIRUS'],\n",
       "   [10383, 10391, 'DATE'],\n",
       "   [10408, 10425, 'DATE'],\n",
       "   [10556, 10562, 'ORGANISM'],\n",
       "   [10584, 10588, 'DATE'],\n",
       "   [10594, 10596, 'DATE'],\n",
       "   [10652, 10660, 'CORONAVIRUS'],\n",
       "   [10693, 10697, 'CORONAVIRUS'],\n",
       "   [10743, 10747, 'CORONAVIRUS'],\n",
       "   [10817, 10819, 'DATE'],\n",
       "   [10822, 10824, 'DATE'],\n",
       "   [10872, 10887, 'ORG'],\n",
       "   [10911, 10913, 'DATE'],\n",
       "   [10948, 10951, 'CARDINAL'],\n",
       "   [10952, 10958, 'DATE'],\n",
       "   [11175, 11184, 'GPE'],\n",
       "   [11216, 11220, 'CORONAVIRUS'],\n",
       "   [11243, 11251, 'DATE'],\n",
       "   [11254, 11256, 'DATE'],\n",
       "   [11314, 11318, 'CORONAVIRUS'],\n",
       "   [11338, 11348, 'DATE'],\n",
       "   [11352, 11354, 'CHEMICAL'],\n",
       "   [11376, 11382, 'ORGANISM'],\n",
       "   [11412, 11422, 'CORONAVIRUS'],\n",
       "   [11446, 11454, 'CORONAVIRUS'],\n",
       "   [11474, 11477, 'CARDINAL'],\n",
       "   [11516, 11524, 'CORONAVIRUS'],\n",
       "   [11526, 11537, 'CARDINAL'],\n",
       "   [11569, 11586, 'DATE'],\n",
       "   [11588, 11590, 'DATE'],\n",
       "   [11591, 11598, 'DATE'],\n",
       "   [11630, 11637, 'CARDINAL'],\n",
       "   [11638, 11645, 'DATE'],\n",
       "   [11684, 11696, 'DATE'],\n",
       "   [11716, 11724, 'CORONAVIRUS'],\n",
       "   [11843, 11845, 'DATE'],\n",
       "   [11893, 11908, 'ORG'],\n",
       "   [11932, 11934, 'DATE'],\n",
       "   [11969, 11972, 'CARDINAL'],\n",
       "   [11973, 11979, 'DATE'],\n",
       "   [12196, 12205, 'GPE'],\n",
       "   [12237, 12241, 'CORONAVIRUS'],\n",
       "   [12264, 12272, 'DATE'],\n",
       "   [12275, 12277, 'DATE'],\n",
       "   [12335, 12339, 'CORONAVIRUS'],\n",
       "   [12359, 12369, 'DATE'],\n",
       "   [12373, 12375, 'CHEMICAL'],\n",
       "   [12397, 12403, 'ORGANISM'],\n",
       "   [12433, 12443, 'CORONAVIRUS'],\n",
       "   [12467, 12475, 'CORONAVIRUS'],\n",
       "   [12495, 12498, 'CARDINAL'],\n",
       "   [12537, 12545, 'CORONAVIRUS'],\n",
       "   [12547, 12558, 'CARDINAL'],\n",
       "   [12590, 12607, 'DATE'],\n",
       "   [12609, 12611, 'DATE'],\n",
       "   [12612, 12619, 'DATE'],\n",
       "   [12651, 12658, 'CARDINAL'],\n",
       "   [12659, 12666, 'DATE'],\n",
       "   [12705, 12717, 'DATE'],\n",
       "   [12737, 12745, 'CORONAVIRUS'],\n",
       "   [12919, 12921, 'DATE'],\n",
       "   [12973, 12981, 'CORONAVIRUS'],\n",
       "   [12991, 13005, 'ORG'],\n",
       "   [13012, 13018, 'CARDINAL'],\n",
       "   [13025, 13029, 'DATE'],\n",
       "   [13031, 13040, 'PERSON'],\n",
       "   [13053, 13057, 'CORONAVIRUS'],\n",
       "   [13063, 13074, 'CORONAVIRUS'],\n",
       "   [13085, 13102, 'ORG'],\n",
       "   [13110, 13114, 'CORONAVIRUS'],\n",
       "   [13115, 13118, 'CORONAVIRUS'],\n",
       "   [13136, 13155, 'WILDLIFE'],\n",
       "   [13157, 13164, 'NORP'],\n",
       "   [13172, 13185, 'WILDLIFE'],\n",
       "   [13213, 13217, 'CORONAVIRUS'],\n",
       "   [13218, 13221, 'CORONAVIRUS'],\n",
       "   [13229, 13233, 'WILDLIFE'],\n",
       "   [13263, 13276, 'CORONAVIRUS'],\n",
       "   [13394, 13402, 'WILDLIFE'],\n",
       "   [13436, 13440, 'CORONAVIRUS'],\n",
       "   [13441, 13444, 'CORONAVIRUS'],\n",
       "   [13462, 13466, 'CARDINAL'],\n",
       "   [13481, 13485, 'CORONAVIRUS'],\n",
       "   [13504, 13527, 'DATE'],\n",
       "   [13529, 13532, 'CARDINAL'],\n",
       "   [13568, 13577, 'GPE'],\n",
       "   [13579, 13584, 'CELL'],\n",
       "   [13621, 13625, 'CARDINAL'],\n",
       "   [13631, 13634, 'CARDINAL'],\n",
       "   [13705, 13708, 'CARDINAL'],\n",
       "   [13709, 13715, 'WILDLIFE'],\n",
       "   [13754, 13758, 'CORONAVIRUS'],\n",
       "   [13759, 13762, 'CORONAVIRUS'],\n",
       "   [13787, 13797, 'CORONAVIRUS'],\n",
       "   [13805, 13813, 'CARDINAL'],\n",
       "   [13839, 13843, 'CORONAVIRUS'],\n",
       "   [13844, 13847, 'CORONAVIRUS'],\n",
       "   [13861, 13927, 'ORG'],\n",
       "   [13931, 13939, 'DATE'],\n",
       "   [13953, 13962, 'PERSON'],\n",
       "   [14005, 14016, 'CORONAVIRUS'],\n",
       "   [14025, 14035, 'CORONAVIRUS'],\n",
       "   [14044, 14055, 'CORONAVIRUS'],\n",
       "   [14070, 14089, 'WILDLIFE'],\n",
       "   [14093, 14095, 'DATE'],\n",
       "   [14119, 14123, 'WILDLIFE'],\n",
       "   [14196, 14206, 'CORONAVIRUS'],\n",
       "   [14287, 14289, 'DATE'],\n",
       "   [14373, 14382, 'WILDLIFE'],\n",
       "   [14401, 14419, 'NORP'],\n",
       "   [14424, 14434, 'CORONAVIRUS'],\n",
       "   [14517, 14526, 'WILDLIFE'],\n",
       "   [14548, 14559, 'CORONAVIRUS'],\n",
       "   [14581, 14588, 'CHEMICAL'],\n",
       "   [14673, 14683, 'CORONAVIRUS'],\n",
       "   [14784, 14787, 'CARDINAL'],\n",
       "   [14813, 14823, 'CORONAVIRUS'],\n",
       "   [14854, 14857, 'ORG'],\n",
       "   [14859, 14873, 'DATE'],\n",
       "   [14924, 14928, 'CORONAVIRUS'],\n",
       "   [14959, 14962, 'CARDINAL'],\n",
       "   [15009, 15018, 'CHEMICAL'],\n",
       "   [15047, 15053, 'LOC'],\n",
       "   [15059, 15066, 'GPE'],\n",
       "   [15090, 15094, 'LOC'],\n",
       "   [15100, 15105, 'CELL'],\n",
       "   [15117, 15125, 'GPE'],\n",
       "   [15127, 15132, 'CHEMICAL'],\n",
       "   [15149, 15155, 'GPE'],\n",
       "   [15158, 15167, 'GPE'],\n",
       "   [15209, 15223, 'GPE'],\n",
       "   [15228, 15229, 'DATE'],\n",
       "   [15230, 15233, 'CARDINAL'],\n",
       "   [15240, 15243, 'CARDINAL'],\n",
       "   [15252, 15254, 'DATE'],\n",
       "   [15296, 15303, 'GPE'],\n",
       "   [15305, 15314, 'GPE'],\n",
       "   [15320, 15326, 'GPE'],\n",
       "   [15360, 15363, 'CARDINAL'],\n",
       "   [15394, 15399, 'CHEMICAL'],\n",
       "   [15405, 15411, 'GPE'],\n",
       "   [15418, 15421, 'CARDINAL'],\n",
       "   [15436, 15448, 'PERSON'],\n",
       "   [15450, 15452, 'DATE'],\n",
       "   [15540, 15542, 'DATE'],\n",
       "   [15594, 15602, 'CORONAVIRUS'],\n",
       "   [15612, 15626, 'ORG'],\n",
       "   [15633, 15639, 'CARDINAL'],\n",
       "   [15646, 15650, 'DATE'],\n",
       "   [15652, 15661, 'PERSON'],\n",
       "   [15674, 15678, 'CORONAVIRUS'],\n",
       "   [15684, 15695, 'CORONAVIRUS'],\n",
       "   [15706, 15723, 'ORG'],\n",
       "   [15731, 15735, 'CORONAVIRUS'],\n",
       "   [15736, 15739, 'CORONAVIRUS'],\n",
       "   [15757, 15776, 'WILDLIFE'],\n",
       "   [15778, 15785, 'NORP'],\n",
       "   [15793, 15806, 'WILDLIFE'],\n",
       "   [15834, 15838, 'CORONAVIRUS'],\n",
       "   [15839, 15842, 'CORONAVIRUS'],\n",
       "   [15850, 15854, 'WILDLIFE'],\n",
       "   [15884, 15897, 'CORONAVIRUS'],\n",
       "   [16015, 16023, 'WILDLIFE'],\n",
       "   [16057, 16061, 'CORONAVIRUS'],\n",
       "   [16062, 16065, 'CORONAVIRUS'],\n",
       "   [16083, 16087, 'CARDINAL'],\n",
       "   [16102, 16106, 'CORONAVIRUS'],\n",
       "   [16125, 16148, 'DATE'],\n",
       "   [16150, 16153, 'CARDINAL'],\n",
       "   [16189, 16198, 'GPE'],\n",
       "   [16200, 16205, 'CELL'],\n",
       "   [16296, 16299, 'CARDINAL'],\n",
       "   [16300, 16306, 'WILDLIFE'],\n",
       "   [16345, 16349, 'CORONAVIRUS'],\n",
       "   [16350, 16353, 'CORONAVIRUS'],\n",
       "   [16378, 16388, 'CORONAVIRUS'],\n",
       "   [16396, 16404, 'CARDINAL'],\n",
       "   [16430, 16434, 'CORONAVIRUS'],\n",
       "   [16435, 16438, 'CORONAVIRUS'],\n",
       "   [16452, 16518, 'ORG'],\n",
       "   [16522, 16530, 'DATE'],\n",
       "   [16544, 16553, 'PERSON'],\n",
       "   [16596, 16607, 'CORONAVIRUS'],\n",
       "   [16616, 16626, 'CORONAVIRUS'],\n",
       "   [16635, 16646, 'CORONAVIRUS'],\n",
       "   [16661, 16680, 'WILDLIFE'],\n",
       "   [16684, 16686, 'DATE'],\n",
       "   [16710, 16714, 'WILDLIFE'],\n",
       "   [16787, 16797, 'CORONAVIRUS'],\n",
       "   [16878, 16880, 'DATE'],\n",
       "   [16964, 16973, 'WILDLIFE'],\n",
       "   [16992, 17010, 'NORP'],\n",
       "   [17015, 17025, 'CORONAVIRUS'],\n",
       "   [17108, 17117, 'WILDLIFE'],\n",
       "   [17139, 17150, 'CORONAVIRUS'],\n",
       "   [17172, 17179, 'CHEMICAL'],\n",
       "   [17264, 17274, 'CORONAVIRUS'],\n",
       "   [17375, 17378, 'CARDINAL'],\n",
       "   [17404, 17414, 'CORONAVIRUS'],\n",
       "   [17453, 17471, 'DATE'],\n",
       "   [17539, 17547, 'CORONAVIRUS'],\n",
       "   [17569, 17572, 'CARDINAL'],\n",
       "   [17631, 17637, 'ORGANISM'],\n",
       "   [17735, 17740, 'CELL'],\n",
       "   [17742, 17751, 'CHEMICAL'],\n",
       "   [17777, 17785, 'CORONAVIRUS'],\n",
       "   [17852, 17855, 'CARDINAL'],\n",
       "   [17884, 17894, 'GPE'],\n",
       "   [17899, 17901, 'DATE'],\n",
       "   [17902, 17905, 'CARDINAL'],\n",
       "   [17913, 17922, 'GPE'],\n",
       "   [17924, 17929, 'CHEMICAL'],\n",
       "   [17960, 17963, 'CARDINAL'],\n",
       "   [17973, 17976, 'CARDINAL'],\n",
       "   [17990, 17993, 'CARDINAL'],\n",
       "   [18022, 18024, 'CARDINAL'],\n",
       "   [18044, 18052, 'CORONAVIRUS'],\n",
       "   [18094, 18099, 'CELL'],\n",
       "   [18136, 18149, 'GPE'],\n",
       "   [18151, 18159, 'GPE'],\n",
       "   [18165, 18170, 'GPE'],\n",
       "   [18238, 18243, 'GPE'],\n",
       "   [18262, 18268, 'ORGANISM'],\n",
       "   [18285, 18290, 'GPE'],\n",
       "   [18312, 18322, 'CORONAVIRUS'],\n",
       "   [18335, 18340, 'CELL'],\n",
       "   [18363, 18368, 'CHEMICAL'],\n",
       "   [18373, 18379, 'GPE'],\n",
       "   [18423, 18427, 'CORONAVIRUS'],\n",
       "   [18458, 18461, 'CARDINAL'],\n",
       "   [18508, 18517, 'CHEMICAL'],\n",
       "   [18546, 18552, 'LOC'],\n",
       "   [18558, 18565, 'GPE'],\n",
       "   [18589, 18593, 'LOC'],\n",
       "   [18599, 18604, 'CELL'],\n",
       "   [18616, 18624, 'GPE'],\n",
       "   [18626, 18631, 'CHEMICAL'],\n",
       "   [18648, 18654, 'GPE'],\n",
       "   [18657, 18666, 'GPE'],\n",
       "   [18708, 18722, 'GPE'],\n",
       "   [18727, 18728, 'DATE'],\n",
       "   [18729, 18732, 'CARDINAL'],\n",
       "   [18739, 18742, 'CARDINAL'],\n",
       "   [18751, 18753, 'DATE'],\n",
       "   [18795, 18802, 'GPE'],\n",
       "   [18804, 18813, 'GPE'],\n",
       "   [18819, 18825, 'GPE'],\n",
       "   [18858, 18861, 'CARDINAL'],\n",
       "   [18892, 18897, 'CHEMICAL'],\n",
       "   [18903, 18909, 'GPE'],\n",
       "   [18916, 18919, 'CARDINAL'],\n",
       "   [18971, 18989, 'DATE'],\n",
       "   [19057, 19065, 'CORONAVIRUS'],\n",
       "   [19087, 19090, 'CARDINAL'],\n",
       "   [19149, 19155, 'ORGANISM'],\n",
       "   [19253, 19258, 'CELL'],\n",
       "   [19260, 19269, 'CHEMICAL'],\n",
       "   [19295, 19303, 'CORONAVIRUS'],\n",
       "   [19370, 19373, 'CARDINAL'],\n",
       "   [19402, 19412, 'GPE'],\n",
       "   [19417, 19419, 'DATE'],\n",
       "   [19420, 19423, 'CARDINAL'],\n",
       "   [19431, 19440, 'GPE'],\n",
       "   [19442, 19447, 'CHEMICAL'],\n",
       "   [19478, 19481, 'CARDINAL'],\n",
       "   [19491, 19494, 'CARDINAL'],\n",
       "   [19508, 19511, 'CARDINAL'],\n",
       "   [19540, 19542, 'CARDINAL'],\n",
       "   [19562, 19570, 'CORONAVIRUS'],\n",
       "   [19612, 19617, 'CELL'],\n",
       "   [19654, 19667, 'GPE'],\n",
       "   [19669, 19677, 'GPE'],\n",
       "   [19683, 19688, 'GPE'],\n",
       "   [19756, 19761, 'GPE'],\n",
       "   [19780, 19786, 'ORGANISM'],\n",
       "   [19803, 19808, 'GPE'],\n",
       "   [19830, 19840, 'CORONAVIRUS'],\n",
       "   [19853, 19858, 'CELL'],\n",
       "   [19881, 19886, 'CHEMICAL'],\n",
       "   [19891, 19897, 'GPE'],\n",
       "   [19959, 19967, 'CORONAVIRUS'],\n",
       "   [19980, 19985, 'CELL'],\n",
       "   [20037, 20047, 'CORONAVIRUS'],\n",
       "   [20111, 20116, 'ORGANISM'],\n",
       "   [20120, 20125, 'ORGANISM'],\n",
       "   [20142, 20152, 'CORONAVIRUS'],\n",
       "   [20180, 20194, 'CHEMICAL'],\n",
       "   [20196, 20198, 'DATE'],\n",
       "   [20200, 20202, 'DATE'],\n",
       "   [20210, 20217, 'CHEMICAL'],\n",
       "   [20276, 20278, 'DATE'],\n",
       "   [20456, 20460, 'CORONAVIRUS'],\n",
       "   [20465, 20473, 'CORONAVIRUS'],\n",
       "   [20496, 20508, 'WILDLIFE'],\n",
       "   [20556, 20568, 'WILDLIFE'],\n",
       "   [20861, 20868, 'CHEMICAL'],\n",
       "   [20877, 20881, 'CORONAVIRUS'],\n",
       "   [20882, 20885, 'CORONAVIRUS'],\n",
       "   [20959, 20969, 'DATE'],\n",
       "   [20975, 20980, 'CELL'],\n",
       "   [21010, 21017, 'CHEMICAL'],\n",
       "   [21022, 21032, 'CORONAVIRUS'],\n",
       "   [21079, 21091, 'CELL'],\n",
       "   [21140, 21144, 'CORONAVIRUS'],\n",
       "   [21149, 21157, 'CORONAVIRUS'],\n",
       "   [21178, 21184, 'DATE'],\n",
       "   [21185, 21194, 'CHEMICAL'],\n",
       "   [21334, 21345, 'CORONAVIRUS'],\n",
       "   [21362, 21397, 'CHEMICAL'],\n",
       "   [21522, 21562, 'ORG'],\n",
       "   [21576, 21581, 'CARDINAL'],\n",
       "   [21586, 21598, 'CHEMICAL'],\n",
       "   [21604, 21612, 'CHEMICAL'],\n",
       "   [21617, 21628, 'CORONAVIRUS'],\n",
       "   [21685, 21698, 'DATE'],\n",
       "   [21843, 21851, 'CHEMICAL'],\n",
       "   [21858, 21862, 'CORONAVIRUS'],\n",
       "   [21863, 21866, 'CORONAVIRUS'],\n",
       "   [21871, 21881, 'CORONAVIRUS'],\n",
       "   [21886, 21890, 'CORONAVIRUS'],\n",
       "   [21927, 21931, 'CORONAVIRUS'],\n",
       "   [21954, 21962, 'CORONAVIRUS'],\n",
       "   [21973, 21977, 'DATE'],\n",
       "   [21979, 21983, 'CORONAVIRUS'],\n",
       "   [22033, 22041, 'CHEMICAL'],\n",
       "   [22138, 22148, 'CHEMICAL'],\n",
       "   [22239, 22247, 'CORONAVIRUS'],\n",
       "   [22282, 22286, 'CORONAVIRUS'],\n",
       "   [22288, 22296, 'CHEMICAL'],\n",
       "   [22339, 22347, 'CORONAVIRUS'],\n",
       "   [22349, 22351, 'DATE'],\n",
       "   [22355, 22364, 'CHEMICAL'],\n",
       "   [22413, 22426, 'ORG'],\n",
       "   [22433, 22442, 'CHEMICAL'],\n",
       "   [22457, 22466, 'CHEMICAL'],\n",
       "   [22474, 22483, 'CHEMICAL'],\n",
       "   [22493, 22504, 'CORONAVIRUS'],\n",
       "   [22517, 22522, 'ORG'],\n",
       "   [22524, 22533, 'CHEMICAL'],\n",
       "   [22569, 22578, 'CHEMICAL'],\n",
       "   [22608, 22627, 'CHEMICAL'],\n",
       "   [22632, 22641, 'CHEMICAL'],\n",
       "   [22722, 22726, 'CORONAVIRUS'],\n",
       "   [22727, 22730, 'CORONAVIRUS'],\n",
       "   [22732, 22734, 'DATE'],\n",
       "   [22736, 22738, 'DATE'],\n",
       "   [22742, 22761, 'CHEMICAL'],\n",
       "   [22810, 22818, 'CORONAVIRUS'],\n",
       "   [23019, 23029, 'DATE'],\n",
       "   [23033, 23038, 'TISSUE'],\n",
       "   [23058, 23098, 'ORG'],\n",
       "   [23133, 23157, 'ORG'],\n",
       "   [23243, 23253, 'CORONAVIRUS'],\n",
       "   [23300, 23310, 'CORONAVIRUS'],\n",
       "   [23311, 23322, 'CORONAVIRUS'],\n",
       "   [23323, 23326, 'ORDINAL'],\n",
       "   [23327, 23336, 'CHEMICAL'],\n",
       "   [23380, 23388, 'CORONAVIRUS'],\n",
       "   [23419, 23432, 'CORONAVIRUS'],\n",
       "   [23434, 23439, 'CORONAVIRUS'],\n",
       "   [23482, 23510, 'CHEMICAL'],\n",
       "   [23512, 23522, 'CHEMICAL'],\n",
       "   [23555, 23564, 'CHEMICAL'],\n",
       "   [23568, 23578, 'CORONAVIRUS'],\n",
       "   [23594, 23596, 'DATE'],\n",
       "   [23604, 23609, 'ORDINAL'],\n",
       "   [23610, 23617, 'ORGANISM'],\n",
       "   [23625, 23627, 'GPE'],\n",
       "   [23668, 23678, 'CHEMICAL'],\n",
       "   [23708, 23715, 'CHEMICAL'],\n",
       "   [23763, 23765, 'DATE'],\n",
       "   [23839, 23846, 'ORGANISM'],\n",
       "   [23910, 23920, 'CHEMICAL'],\n",
       "   [23938, 23946, 'CORONAVIRUS'],\n",
       "   [23976, 23980, 'ORDINAL'],\n",
       "   [23982, 23986, 'DATE'],\n",
       "   [23990, 23995, 'GPE'],\n",
       "   [24000, 24007, 'GPE'],\n",
       "   [24052, 24066, 'CHEMICAL'],\n",
       "   [24072, 24074, 'DATE'],\n",
       "   [24078, 24082, 'CORONAVIRUS'],\n",
       "   [24087, 24098, 'GPE'],\n",
       "   [24138, 24141, 'LAW'],\n",
       "   [24157, 24161, 'CORONAVIRUS'],\n",
       "   [24217, 24230, 'CHEMICAL'],\n",
       "   [24285, 24289, 'CARDINAL'],\n",
       "   [24300, 24311, 'CORONAVIRUS'],\n",
       "   [24315, 24326, 'CORONAVIRUS'],\n",
       "   [24330, 24341, 'CORONAVIRUS'],\n",
       "   [24349, 24360, 'CORONAVIRUS'],\n",
       "   [24373, 24383, 'CORONAVIRUS'],\n",
       "   [24388, 24392, 'CORONAVIRUS'],\n",
       "   [24393, 24396, 'CORONAVIRUS'],\n",
       "   [24408, 24419, 'CORONAVIRUS'],\n",
       "   [24430, 24441, 'CORONAVIRUS'],\n",
       "   [24470, 24480, 'CORONAVIRUS'],\n",
       "   [24484, 24496, 'CARDINAL'],\n",
       "   [24527, 24531, 'CORONAVIRUS'],\n",
       "   [24549, 24552, 'WILDLIFE'],\n",
       "   [24565, 24573, 'GPE'],\n",
       "   [24670, 24674, 'CORONAVIRUS'],\n",
       "   [24699, 24711, 'CORONAVIRUS'],\n",
       "   [24736, 24741, 'CARDINAL'],\n",
       "   [24765, 24776, 'CORONAVIRUS'],\n",
       "   [24793, 24798, 'ORGANISM'],\n",
       "   [24799, 24803, 'CORONAVIRUS'],\n",
       "   [24804, 24807, 'CORONAVIRUS'],\n",
       "   [24834, 24837, 'WILDLIFE'],\n",
       "   [24838, 24849, 'CORONAVIRUS'],\n",
       "   [24851, 24854, 'WILDLIFE'],\n",
       "   [24868, 24876, 'NORP'],\n",
       "   [24896, 24901, 'CELL'],\n",
       "   [24939, 24951, 'CORONAVIRUS'],\n",
       "   [24977, 24996, 'ORG'],\n",
       "   [25009, 25019, 'CORONAVIRUS'],\n",
       "   [25024, 25028, 'CORONAVIRUS'],\n",
       "   [25029, 25032, 'CORONAVIRUS'],\n",
       "   [25036, 25044, 'CHEMICAL'],\n",
       "   [25095, 25105, 'CORONAVIRUS'],\n",
       "   [25110, 25114, 'CORONAVIRUS'],\n",
       "   [25115, 25118, 'CORONAVIRUS'],\n",
       "   [25124, 25138, 'TISSUE'],\n",
       "   [25155, 25165, 'CHEMICAL'],\n",
       "   [25173, 25182, 'CHEMICAL'],\n",
       "   [25198, 25201, 'CARDINAL'],\n",
       "   [25260, 25264, 'CORONAVIRUS'],\n",
       "   [25265, 25268, 'CORONAVIRUS'],\n",
       "   [25273, 25283, 'CORONAVIRUS'],\n",
       "   [25293, 25296, 'CHEMICAL'],\n",
       "   [25358, 25361, 'CHEMICAL'],\n",
       "   [25380, 25385, 'WORK_OF_ART'],\n",
       "   [25459, 25462, 'CHEMICAL'],\n",
       "   [25464, 25469, 'ORG'],\n",
       "   [25474, 25478, 'CHEMICAL'],\n",
       "   [25601, 25606, 'ORG'],\n",
       "   [25676, 25679, 'CHEMICAL'],\n",
       "   [25681, 25686, 'ORG'],\n",
       "   [25691, 25695, 'CHEMICAL'],\n",
       "   [25818, 25823, 'ORG'],\n",
       "   [25910, 25920, 'CORONAVIRUS'],\n",
       "   [25925, 25929, 'CORONAVIRUS'],\n",
       "   [25930, 25933, 'CORONAVIRUS'],\n",
       "   [25978, 25988, 'CORONAVIRUS'],\n",
       "   [26020, 26024, 'CORONAVIRUS'],\n",
       "   [26025, 26028, 'CORONAVIRUS'],\n",
       "   [26030, 26038, 'CORONAVIRUS'],\n",
       "   [26044, 26054, 'CORONAVIRUS'],\n",
       "   [26120, 26130, 'CORONAVIRUS'],\n",
       "   [26177, 26180, 'CARDINAL'],\n",
       "   [26181, 26185, 'CORONAVIRUS'],\n",
       "   [26186, 26189, 'CORONAVIRUS'],\n",
       "   [26202, 26205, 'CARDINAL'],\n",
       "   [26206, 26214, 'CORONAVIRUS'],\n",
       "   [26288, 26292, 'CORONAVIRUS'],\n",
       "   [26293, 26296, 'CORONAVIRUS'],\n",
       "   [26321, 26331, 'CORONAVIRUS'],\n",
       "   [26345, 26353, 'CORONAVIRUS'],\n",
       "   [26355, 26363, 'CHEMICAL'],\n",
       "   [26406, 26410, 'CORONAVIRUS'],\n",
       "   [26411, 26414, 'CORONAVIRUS'],\n",
       "   [26416, 26424, 'CORONAVIRUS'],\n",
       "   [26430, 26440, 'CORONAVIRUS'],\n",
       "   [26506, 26516, 'CORONAVIRUS'],\n",
       "   [26563, 26566, 'CARDINAL'],\n",
       "   [26567, 26571, 'CORONAVIRUS'],\n",
       "   [26572, 26575, 'CORONAVIRUS'],\n",
       "   [26588, 26591, 'CARDINAL'],\n",
       "   [26592, 26600, 'CORONAVIRUS'],\n",
       "   [26674, 26678, 'CORONAVIRUS'],\n",
       "   [26679, 26682, 'CORONAVIRUS'],\n",
       "   [26707, 26717, 'CORONAVIRUS'],\n",
       "   [26731, 26739, 'CORONAVIRUS'],\n",
       "   [26741, 26749, 'CHEMICAL'],\n",
       "   [26793, 26809, 'CHEMICAL'],\n",
       "   [26813, 26823, 'CORONAVIRUS'],\n",
       "   [26850, 26854, 'CORONAVIRUS'],\n",
       "   [26855, 26858, 'CORONAVIRUS'],\n",
       "   [26957, 26967, 'CORONAVIRUS'],\n",
       "   [27000, 27007, 'CARDINAL'],\n",
       "   [27029, 27033, 'CORONAVIRUS'],\n",
       "   [27034, 27037, 'CORONAVIRUS'],\n",
       "   [27092, 27096, 'CORONAVIRUS'],\n",
       "   [27097, 27100, 'CORONAVIRUS'],\n",
       "   [27105, 27115, 'CORONAVIRUS'],\n",
       "   [27137, 27140, 'CARDINAL'],\n",
       "   [27170, 27180, 'CORONAVIRUS'],\n",
       "   [27189, 27208, 'CHEMICAL'],\n",
       "   [27212, 27216, 'CORONAVIRUS'],\n",
       "   [27217, 27220, 'CORONAVIRUS'],\n",
       "   [27226, 27236, 'CHEMICAL'],\n",
       "   [27257, 27267, 'CORONAVIRUS'],\n",
       "   [27317, 27322, 'CARDINAL'],\n",
       "   [27336, 27341, 'ORGANISM'],\n",
       "   [27342, 27346, 'CORONAVIRUS'],\n",
       "   [27347, 27350, 'CORONAVIRUS'],\n",
       "   [27374, 27384, 'CORONAVIRUS'],\n",
       "   [27464, 27474, 'CHEMICAL'],\n",
       "   [27500, 27504, 'CORONAVIRUS'],\n",
       "   [27505, 27508, 'CORONAVIRUS'],\n",
       "   [27644, 27657, 'CHEMICAL'],\n",
       "   [27687, 27708, 'CHEMICAL'],\n",
       "   [27753, 27756, 'CARDINAL'],\n",
       "   [27795, 27805, 'CORONAVIRUS'],\n",
       "   [27839, 27843, 'CORONAVIRUS'],\n",
       "   [27897, 27901, 'CORONAVIRUS'],\n",
       "   [27926, 27936, 'CORONAVIRUS'],\n",
       "   [27948, 27958, 'CHEMICAL'],\n",
       "   [28018, 28028, 'CHEMICAL'],\n",
       "   [28054, 28058, 'CORONAVIRUS'],\n",
       "   [28059, 28062, 'CORONAVIRUS'],\n",
       "   [28112, 28122, 'CORONAVIRUS'],\n",
       "   [28134, 28144, 'CHEMICAL'],\n",
       "   [28172, 28182, 'CORONAVIRUS'],\n",
       "   [28202, 28212, 'CHEMICAL'],\n",
       "   [28242, 28246, 'CORONAVIRUS'],\n",
       "   [28247, 28250, 'CORONAVIRUS'],\n",
       "   [28296, 28307, 'CHEMICAL'],\n",
       "   [28337, 28347, 'CORONAVIRUS'],\n",
       "   [28379, 28395, 'CHEMICAL'],\n",
       "   [28433, 28437, 'CORONAVIRUS'],\n",
       "   [28438, 28441, 'CORONAVIRUS'],\n",
       "   [28456, 28463, 'NORP'],\n",
       "   [28495, 28505, 'CORONAVIRUS'],\n",
       "   [28702, 28712, 'CORONAVIRUS'],\n",
       "   [28775, 28778, 'CARDINAL'],\n",
       "   [28779, 28782, 'WILDLIFE'],\n",
       "   [28783, 28787, 'CORONAVIRUS'],\n",
       "   [28793, 28797, 'CORONAVIRUS'],\n",
       "   [28799, 28802, 'WILDLIFE'],\n",
       "   [28819, 28822, 'WILDLIFE'],\n",
       "   [28839, 28844, 'ORGANISM'],\n",
       "   [28845, 28849, 'CORONAVIRUS'],\n",
       "   [28850, 28853, 'CORONAVIRUS'],\n",
       "   [28913, 28915, 'CARDINAL'],\n",
       "   [29029, 29033, 'CORONAVIRUS'],\n",
       "   [29034, 29037, 'CORONAVIRUS'],\n",
       "   [29309, 29327, 'CELL'],\n",
       "   [29341, 29346, 'CELL'],\n",
       "   [29385, 29390, 'CELL'],\n",
       "   [29451, 29455, 'CORONAVIRUS'],\n",
       "   [29456, 29459, 'CORONAVIRUS'],\n",
       "   [29486, 29499, 'TISSUE'],\n",
       "   [29545, 29564, 'CHEMICAL'],\n",
       "   [29795, 29798, 'CARDINAL'],\n",
       "   [29802, 29805, 'CORONAVIRUS'],\n",
       "   [29859, 29862, 'CORONAVIRUS'],\n",
       "   [29886, 29894, 'CHEMICAL'],\n",
       "   [29895, 29926, 'PERSON'],\n",
       "   [29958, 29962, 'CORONAVIRUS'],\n",
       "   [29963, 29966, 'CORONAVIRUS'],\n",
       "   [30066, 30068, 'DATE'],\n",
       "   [30070, 30073, 'CARDINAL'],\n",
       "   [30075, 30078, 'CARDINAL'],\n",
       "   [30150, 30158, 'CHEMICAL'],\n",
       "   [30163, 30167, 'CORONAVIRUS'],\n",
       "   [30168, 30171, 'CORONAVIRUS'],\n",
       "   [30197, 30211, 'CELL'],\n",
       "   [30213, 30216, 'CARDINAL'],\n",
       "   [30235, 30248, 'CHEMICAL'],\n",
       "   [30299, 30307, 'CHEMICAL'],\n",
       "   [30352, 30356, 'CORONAVIRUS'],\n",
       "   [30430, 30444, 'CHEMICAL'],\n",
       "   [30460, 30466, 'CHEMICAL'],\n",
       "   [30500, 30502, 'CARDINAL'],\n",
       "   [30503, 30517, 'CHEMICAL'],\n",
       "   [30518, 30526, 'CHEMICAL'],\n",
       "   [30695, 30698, 'CARDINAL'],\n",
       "   [30719, 30726, 'CELL'],\n",
       "   [30732, 30755, 'CHEMICAL'],\n",
       "   [30866, 30890, 'CELL'],\n",
       "   [30892, 30902, 'CHEMICAL'],\n",
       "   [30981, 30989, 'PERSON'],\n",
       "   [31040, 31050, 'CORONAVIRUS'],\n",
       "   [31137, 31141, 'CHEMICAL'],\n",
       "   [31142, 31145, 'CORONAVIRUS'],\n",
       "   [31146, 31159, 'CHEMICAL'],\n",
       "   [31162, 31170, 'CARDINAL'],\n",
       "   [31216, 31226, 'ORGANISM'],\n",
       "   [31234, 31242, 'CHEMICAL'],\n",
       "   [31247, 31251, 'CORONAVIRUS'],\n",
       "   [31252, 31255, 'CORONAVIRUS'],\n",
       "   [31257, 31262, 'CARDINAL'],\n",
       "   [31263, 31274, 'CHEMICAL'],\n",
       "   [31306, 31316, 'CORONAVIRUS'],\n",
       "   [31317, 31330, 'CHEMICAL'],\n",
       "   [31336, 31339, 'CARDINAL'],\n",
       "   [31361, 31370, 'PERSON'],\n",
       "   [31384, 31394, 'CORONAVIRUS'],\n",
       "   [31405, 31414, 'CHEMICAL'],\n",
       "   [31433, 31437, 'WILDLIFE'],\n",
       "   [31439, 31445, 'WILDLIFE'],\n",
       "   [31460, 31465, 'LIVESTOCK'],\n",
       "   [31475, 31479, 'ORGANISM'],\n",
       "   [31481, 31484, 'CARDINAL'],\n",
       "   [31520, 31524, 'CORONAVIRUS'],\n",
       "   [31525, 31528, 'CORONAVIRUS'],\n",
       "   [31538, 31548, 'CORONAVIRUS'],\n",
       "   [31559, 31568, 'CHEMICAL'],\n",
       "   [31591, 31596, 'ORGANISM'],\n",
       "   [31597, 31601, 'CORONAVIRUS'],\n",
       "   [31602, 31605, 'CORONAVIRUS'],\n",
       "   [31607, 31616, 'DATE'],\n",
       "   [31645, 31650, 'ORGANISM'],\n",
       "   [31651, 31655, 'CORONAVIRUS'],\n",
       "   [31656, 31659, 'CORONAVIRUS'],\n",
       "   [31661, 31670, 'DATE'],\n",
       "   [31673, 31676, 'CARDINAL'],\n",
       "   [31716, 31719, 'CARDINAL'],\n",
       "   [31753, 31763, 'CORONAVIRUS'],\n",
       "   [31828, 31831, 'WILDLIFE'],\n",
       "   [31837, 31841, 'CORONAVIRUS'],\n",
       "   [31842, 31845, 'CORONAVIRUS'],\n",
       "   [31878, 31882, 'CORONAVIRUS'],\n",
       "   [31883, 31886, 'CORONAVIRUS'],\n",
       "   [31915, 31921, 'ORGANISM'],\n",
       "   [31927, 31937, 'CHEMICAL'],\n",
       "   [32020, 32028, 'CORONAVIRUS'],\n",
       "   [32051, 32061, 'DATE'],\n",
       "   [32074, 32086, 'CARDINAL'],\n",
       "   [32129, 32134, 'GPE'],\n",
       "   [32473, 32483, 'CORONAVIRUS'],\n",
       "   [32507, 32514, 'CHEMICAL'],\n",
       "   [32625, 32630, 'CARDINAL'],\n",
       "   [32639, 32643, 'CORONAVIRUS'],\n",
       "   [32689, 32692, 'CARDINAL'],\n",
       "   [32700, 32703, 'CARDINAL'],\n",
       "   [32731, 32752, 'CORONAVIRUS'],\n",
       "   [32809, 32813, 'CARDINAL'],\n",
       "   [32814, 32819, 'ORGANISM'],\n",
       "   [32820, 32824, 'CORONAVIRUS'],\n",
       "   [32826, 32835, 'CORONAVIRUS'],\n",
       "   [32837, 32846, 'CORONAVIRUS'],\n",
       "   [32848, 32857, 'CORONAVIRUS'],\n",
       "   [32945, 32962, 'CHEMICAL'],\n",
       "   [33019, 33022, 'CARDINAL'],\n",
       "   [33044, 33054, 'CORONAVIRUS'],\n",
       "   [33082, 33092, 'CORONAVIRUS'],\n",
       "   [33100, 33109, 'CARDINAL'],\n",
       "   [33130, 33134, 'CORONAVIRUS'],\n",
       "   [33135, 33138, 'CORONAVIRUS'],\n",
       "   [33186, 33202, 'CHEMICAL'],\n",
       "   [33206, 33216, 'CORONAVIRUS'],\n",
       "   [33235, 33239, 'CORONAVIRUS'],\n",
       "   [33240, 33243, 'CORONAVIRUS'],\n",
       "   [33315, 33319, 'CORONAVIRUS'],\n",
       "   [33351, 33359, 'CORONAVIRUS'],\n",
       "   [33407, 33411, 'CORONAVIRUS'],\n",
       "   [33412, 33415, 'CORONAVIRUS'],\n",
       "   [33417, 33425, 'CORONAVIRUS'],\n",
       "   [33430, 33433, 'CARDINAL'],\n",
       "   [33461, 33465, 'CORONAVIRUS'],\n",
       "   [33495, 33503, 'CORONAVIRUS'],\n",
       "   [33594, 33601, 'CHEMICAL'],\n",
       "   [33634, 33640, 'WILDLIFE'],\n",
       "   [33642, 33645, 'CARDINAL'],\n",
       "   [33669, 33681, 'GPE'],\n",
       "   [33772, 33776, 'CORONAVIRUS'],\n",
       "   [33781, 33785, 'CORONAVIRUS'],\n",
       "   [33810, 33814, 'CORONAVIRUS'],\n",
       "   [33819, 33823, 'CORONAVIRUS'],\n",
       "   [33884, 33894, 'CORONAVIRUS'],\n",
       "   [33935, 33943, 'CORONAVIRUS'],\n",
       "   [34005, 34009, 'CORONAVIRUS'],\n",
       "   [34010, 34013, 'CORONAVIRUS'],\n",
       "   [34015, 34023, 'CORONAVIRUS'],\n",
       "   [34029, 34039, 'CORONAVIRUS'],\n",
       "   [34084, 34108, 'ORGANISM'],\n",
       "   [34155, 34165, 'CORONAVIRUS'],\n",
       "   [34217, 34225, 'CORONAVIRUS'],\n",
       "   [34391, 34401, 'CORONAVIRUS'],\n",
       "   [34449, 34457, 'CORONAVIRUS'],\n",
       "   [34497, 34507, 'CORONAVIRUS'],\n",
       "   [34512, 34526, 'CHEMICAL'],\n",
       "   [34562, 34569, 'CHEMICAL'],\n",
       "   [34614, 34624, 'CORONAVIRUS'],\n",
       "   [34675, 34679, 'CORONAVIRUS'],\n",
       "   [34680, 34683, 'CORONAVIRUS'],\n",
       "   [34684, 34691, 'CHEMICAL'],\n",
       "   [34727, 34737, 'CORONAVIRUS'],\n",
       "   [34744, 34754, 'CORONAVIRUS'],\n",
       "   [34815, 34819, 'CORONAVIRUS'],\n",
       "   [34820, 34823, 'CORONAVIRUS'],\n",
       "   [34876, 34886, 'CORONAVIRUS'],\n",
       "   [35094, 35104, 'CORONAVIRUS'],\n",
       "   [35132, 35140, 'CORONAVIRUS'],\n",
       "   [35174, 35178, 'CORONAVIRUS'],\n",
       "   [35192, 35202, 'CHEMICAL'],\n",
       "   [35240, 35250, 'CORONAVIRUS'],\n",
       "   [35266, 35294, 'CHEMICAL'],\n",
       "   [35331, 35339, 'CORONAVIRUS'],\n",
       "   [35350, 35360, 'CORONAVIRUS'],\n",
       "   [35433, 35443, 'CORONAVIRUS'],\n",
       "   [35522, 35532, 'CORONAVIRUS'],\n",
       "   [35621, 35625, 'CHEMICAL'],\n",
       "   [35630, 35639, 'DATE'],\n",
       "   [35678, 35688, 'CORONAVIRUS'],\n",
       "   [35690, 35711, 'CORONAVIRUS'],\n",
       "   [35781, 35802, 'CHEMICAL'],\n",
       "   [35804, 35812, 'CHEMICAL'],\n",
       "   [35849, 35859, 'CORONAVIRUS'],\n",
       "   [35924, 35927, 'ORG'],\n",
       "   [35968, 35971, 'GPE'],\n",
       "   [36010, 36013, 'GPE'],\n",
       "   [36148, 36151, 'ORG'],\n",
       "   [36154, 36167, 'GPE'],\n",
       "   [36214, 36217, 'CHEMICAL'],\n",
       "   [36229, 36232, 'ORG']]}]"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "TRAIN[31]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy.util import minibatch, compounding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy.training.example import Example"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "def train_spacy(data, iterations):\n",
    "    TRAIN_DATA = data\n",
    "    nlp = spacy.blank(\"en\")\n",
    "    if \"ner\" not in nlp.pipe_names:\n",
    "        ner = nlp.create_pipe(\"ner\")\n",
    "        nlp.add_pipe(\"ner\", last=True)\n",
    "    for _, annotations in TRAIN_DATA:\n",
    "        for ent in annotations.get(\"entities\"):\n",
    "            ner.add_label(ent[2]) # grab label of each entity\n",
    "    other_pipes = [pipe for pipe in nlp.pipe_names if pipe != \"ner\"]\n",
    "    with nlp.disable_pipes(*other_pipes):\n",
    "        optimizer = nlp.begin_training()\n",
    "        for itn in range(iterations):\n",
    "            print(\"Starting Iteartion \" + str(itn))\n",
    "            random.shuffle(TRAIN_DATA)\n",
    "            losses = {}\n",
    "\n",
    "#             for batch in spacy.util.minibatch(TRAIN_DATA, size=2):\n",
    "#                 for text, annotations in batch:\n",
    "#                     doc = nlp.make_doc(text)\n",
    "#                     example = Example.from_dict(doc, annotations)\n",
    "#                     nlp.update([example], sgd=optimizer,losses=losses, drop=0.3)\n",
    "            for batch in minibatch(TRAIN_DATA, size=8):\n",
    "                for text, annotations in batch:\n",
    "                    doc = nlp.make_doc(text)\n",
    "                    example = Example.from_dict(doc, annotations)\n",
    "                    nlp.update([example], drop=0.2, sgd=optimizer, losses=losses)\n",
    "#             for text, annotations in TRAIN_DATA:\n",
    "#                 nlp.update(\n",
    "#                     text, \n",
    "#                     annotations, \n",
    "#                     drop=0.2,\n",
    "#                     sgd=optimizer,\n",
    "#                     losses=losses\n",
    "#                 )\n",
    "            print(losses)\n",
    "    return (nlp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting Iteartion 0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A conceptual model for the outbreak of Coronavirus...\" with entities \"[[2, 18, 'CHEMICAL'], [39, 50, 'CORONAVIRUS'], [59...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Transmission routes of 2019-nCoV and controls in d...\" with entities \"[[23, 32, 'CORONAVIRUS'], [49, 64, 'CHEMICAL'], [7...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"An updated estimation of the risk of transmission ...\" with entities \"[[63, 74, 'CORONAVIRUS'], [76, 85, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Potential Rapid Diagnostics, Vaccine and Therapeut...\" with entities \"[[29, 36, 'CHEMICAL'], [41, 53, 'CHEMICAL'], [58, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A distinct name is needed for the new coronavirus ...\" with entities \"[[38, 49, 'CORONAVIRUS'], [55, 66, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A potential role for integrins in host cell entry ...\" with entities \"[[21, 30, 'CHEMICAL'], [34, 43, 'CHEMICAL'], [53, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 20225.71152383089}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Statistics-Based Predictions of Coronavirus Epidem...\" with entities \"[[32, 43, 'CORONAVIRUS'], [66, 80, 'GPE'], [156, 1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Passengers' destinations from China: low risk of N...\" with entities \"[[30, 45, 'ORGANISM'], [55, 66, 'CORONAVIRUS'], [6...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Middle East respiratory syndrome coronavirus (MERS...\" with entities \"[[0, 44, 'CORONAVIRUS'], [46, 54, 'CORONAVIRUS'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Overview of The 2019 Novel Coronavirus (2019-nCoV)...\" with entities \"[[16, 20, 'DATE'], [27, 38, 'CORONAVIRUS'], [40, 4...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Return of the Coronavirus: 2019-nCoV The emergence...\" with entities \"[[14, 25, 'CORONAVIRUS'], [27, 36, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"2019-nCoV (Wuhan virus), a novel Coronavirus: Huma...\" with entities \"[[0, 9, 'CORONAVIRUS'], [11, 22, 'PERSON'], [33, 4...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 28184.039924873505}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Nonstructural proteins NS7b and NS8 are likely to ...\" with entities \"[[99, 108, 'CORONAVIRUS'], [113, 120, 'ORDINAL'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Li Wenliang, a face to the frontline healthcare wo...\" with entities \"[[0, 11, 'CHEMICAL'], [27, 47, 'CHEMICAL'], [60, 6...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Epitope-based peptide vaccine design and target si...\" with entities \"[[0, 7, 'CHEMICAL'], [14, 21, 'CHEMICAL'], [22, 29...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"The outbreak of COVID-19: An overview In late Dece...\" with entities \"[[16, 24, 'CORONAVIRUS'], [85, 96, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A mathematical model for simulating the phase-base...\" with entities \"[[80, 91, 'CORONAVIRUS'], [157, 168, 'CORONAVIRUS'...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Estimating the Unreported Number of Novel Coronavi...\" with entities \"[[42, 53, 'CORONAVIRUS'], [55, 64, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 33334.634743078146}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Preliminary Identification of Potential Vaccine Ta...\" with entities \"[[40, 47, 'CHEMICAL'], [64, 72, 'CORONAVIRUS'], [7...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"On the Coronavirus (COVID-19) Outbreak and the Sma...\" with entities \"[[7, 18, 'CORONAVIRUS'], [20, 28, 'CORONAVIRUS'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Communicating the Risk of Death from Novel Coronav...\" with entities \"[[43, 54, 'CORONAVIRUS'], [64, 72, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Genome Detective Coronavirus Typing Tool for rapid...\" with entities \"[[96, 107, 'CORONAVIRUS'], [147, 156, 'ORG'], [158...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Critical care response to a hospital outbreak of t...\" with entities \"[[53, 62, 'CORONAVIRUS'], [76, 84, 'GPE'], [86, 91...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 36171.34465246834}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"COVID-19 outbreak on the Diamond Princess cruise s...\" with entities \"[[0, 8, 'CORONAVIRUS'], [110, 123, 'CHEMICAL'], [1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Real-time forecasts of the 2019-nCoV epidemic in C...\" with entities \"[[27, 36, 'CORONAVIRUS'], [49, 54, 'CELL'], [76, 8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Recommended psychological crisis intervention resp...\" with entities \"[[62, 66, 'DATE'], [73, 84, 'CORONAVIRUS'], [107, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Revisiting the dangers of the coronavirus in the o...\" with entities \"[[30, 41, 'CORONAVIRUS'], [128, 137, 'CORONAVIRUS'...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Early transmission patterns of coronavirus disease...\" with entities \"[[31, 42, 'CORONAVIRUS'], [51, 55, 'DATE'], [57, 6...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A strategy to prevent future pandemics similar to ...\" with entities \"[[54, 63, 'CORONAVIRUS'], [81, 84, 'WILDLIFE'], [9...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Emergence of Novel Coronavirus 2019-nCoV: Need for...\" with entities \"[[19, 30, 'CORONAVIRUS'], [31, 40, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A new coronavirus associated with human respirator...\" with entities \"[[6, 17, 'CORONAVIRUS'], [63, 68, 'CELL'], [107, 1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 39563.86795224249}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Effectiveness for the Response to COVID-19: The ME...\" with entities \"[[34, 42, 'CORONAVIRUS'], [109, 128, 'ORG'], [193,...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Initial Cluster of Novel Coronavirus (2019-nCoV) I...\" with entities \"[[25, 36, 'CORONAVIRUS'], [38, 47, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"HRCT Imaging Features in Representative Imported C...\" with entities \"[[0, 12, 'PERSON'], [58, 62, 'DATE'], [69, 80, 'CO...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Potential role of inanimate surfaces for the sprea...\" with entities \"[[55, 68, 'CORONAVIRUS'], [141, 152, 'CORONAVIRUS'...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Pathogenicity and Transmissibility of 2019-nCoV—A ...\" with entities \"[[38, 47, 'CORONAVIRUS'], [91, 107, 'CHEMICAL'], [...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"The reproductive number of COVID-19 is higher comp...\" with entities \"[[27, 35, 'CORONAVIRUS'], [58, 62, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Incubation period of 2019 novel coronavirus (2019-...\" with entities \"[[21, 25, 'DATE'], [32, 43, 'CORONAVIRUS'], [45, 5...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 41030.75133119679}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Puzzle of highly pathogenic human coronaviruses (2...\" with entities \"[[34, 47, 'CORONAVIRUS'], [49, 58, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Estimation of the reproductive number of Novel Cor...\" with entities \"[[47, 58, 'CORONAVIRUS'], [60, 68, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A rapid advice guideline for the diagnosis and tre...\" with entities \"[[2, 24, 'CHEMICAL'], [60, 64, 'DATE'], [71, 82, '...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Incubation Period and Other Epidemiological Charac...\" with entities \"[[63, 67, 'DATE'], [74, 85, 'CORONAVIRUS'], [200, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Serial interval of novel coronavirus (COVID-19) in...\" with entities \"[[0, 15, 'CHEMICAL'], [25, 36, 'CORONAVIRUS'], [38...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Preliminary estimation of the basic reproduction n...\" with entities \"[[30, 55, 'CHEMICAL'], [65, 76, 'CORONAVIRUS'], [7...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Case of the Index Patient Who Caused Tertiary Tran...\" with entities \"[[12, 25, 'ORG'], [62, 73, 'CORONAVIRUS'], [82, 86...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Distinct Roles for Sialoside and Protein Receptors...\" with entities \"[[19, 28, 'CHEMICAL'], [41, 50, 'CHEMICAL'], [54, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 45743.80072858992}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Moral imperative for the immediate release of 2019...\" with entities \"[[46, 55, 'CORONAVIRUS'], [394, 399, 'ORGANISM'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Therapeutic strategies in an outbreak scenario to ...\" with entities \"[[0, 22, 'CHEMICAL'], [66, 77, 'CORONAVIRUS'], [93...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Comparative Serological Study for the Prevalence o...\" with entities \"[[57, 73, 'CORONAVIRUS'], [74, 84, 'CHEMICAL'], [1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Optimization Method for Forecasting Confirmed Case...\" with entities \"[[55, 63, 'CORONAVIRUS'], [67, 72, 'CELL'], [76, 8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Comprehensive Genomic Characterization Analysis of...\" with entities \"[[62, 67, 'CELL'], [87, 98, 'CORONAVIRUS'], [123, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 48703.05967696456}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Estimation of the Transmission Risk of the 2019-nC...\" with entities \"[[43, 52, 'CORONAVIRUS'], [77, 90, 'CHEMICAL'], [1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"First case of Coronavirus Disease 2019 (COVID-19) ...\" with entities \"[[0, 5, 'ORDINAL'], [14, 25, 'CORONAVIRUS'], [34, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Real-Time Estimation of the Risk of Death from Nov...\" with entities \"[[53, 64, 'CORONAVIRUS'], [66, 74, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"2019-novel Coronavirus (2019-nCoV): estimating the...\" with entities \"[[0, 4, 'DATE'], [11, 22, 'CORONAVIRUS'], [24, 33,...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"2019-nCoV in context: lessons learned?  The emerge...\" with entities \"[[0, 9, 'CORONAVIRUS'], [63, 74, 'CORONAVIRUS'], [...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"First two months of the 2019 Coronavirus Disease (...\" with entities \"[[0, 16, 'DATE'], [24, 28, 'DATE'], [29, 40, 'CORO...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 50953.61245422627}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Science in the fight against the novel coronavirus...\" with entities \"[[39, 50, 'CORONAVIRUS'], [63, 76, 'CHEMICAL'], [9...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Potential Maternal and Infant Outcomes from (Wuhan...\" with entities \"[[45, 50, 'GPE'], [52, 63, 'CORONAVIRUS'], [64, 73...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"COVID-19 in the Shadows of MERS-CoV in the Kingdom...\" with entities \"[[0, 8, 'CORONAVIRUS'], [27, 35, 'CORONAVIRUS'], [...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Clinical characteristics of novel coronavirus case...\" with entities \"[[34, 45, 'CORONAVIRUS'], [55, 63, 'DATE'], [112, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Potential Factors Influencing Repeated SARS Outbre...\" with entities \"[[39, 43, 'CORONAVIRUS'], [57, 62, 'CELL'], [70, 8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 53581.82704534569}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Novel coronavirus infection during the 2019–2020 e...\" with entities \"[[6, 17, 'CORONAVIRUS'], [39, 48, 'DATE'], [108, 1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Six weeks into the 2019 coronavirus disease (COVID...\" with entities \"[[0, 9, 'DATE'], [19, 23, 'DATE'], [24, 35, 'CORON...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"A pneumonia outbreak associated with a new coronav...\" with entities \"[[43, 54, 'CORONAVIRUS'], [67, 70, 'WILDLIFE'], [8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"From SARS to COVID-19: A previously unknown SARS-C...\" with entities \"[[5, 9, 'CORONAVIRUS'], [13, 21, 'CORONAVIRUS'], [...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Remdesivir and chloroquine effectively inhibit the...\" with entities \"[[0, 10, 'CHEMICAL'], [15, 26, 'CHEMICAL'], [74, 8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Effectiveness of airport screening at detecting tr...\" with entities \"[[48, 58, 'ORGANISM'], [79, 90, 'CORONAVIRUS'], [9...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Differential diagnosis of illness in patients unde...\" with entities \"[[80, 91, 'CORONAVIRUS'], [93, 103, 'CORONAVIRUS']...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"The continuing 2019-nCoV epidemic threat of novel ...\" with entities \"[[15, 24, 'CORONAVIRUS'], [50, 63, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 55517.85022570235}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Feasibility of controlling COVID-19 outbreaks by i...\" with entities \"[[27, 35, 'CORONAVIRUS'], [123, 138, 'CHEMICAL'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Angiotensin-converting enzyme 2 (ACE2) as a SARS-C...\" with entities \"[[44, 54, 'CORONAVIRUS'], [55, 63, 'CHEMICAL'], [1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Comparative genetic analysis of the novel coronavi...\" with entities \"[[42, 53, 'CORONAVIRUS'], [55, 64, 'CORONAVIRUS'],...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Identification of a novel coronavirus causing seve...\" with entities \"[[26, 37, 'CORONAVIRUS'], [66, 71, 'ORGANISM'], [1...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 57201.918305276675}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Phase-adjusted estimation of the number of Coronav...\" with entities \"[[43, 54, 'CORONAVIRUS'], [63, 67, 'DATE'], [77, 8...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"The coronavirus 2019-nCoV epidemic: Is hindsight 2...\" with entities \"[[4, 15, 'CORONAVIRUS'], [16, 25, 'CORONAVIRUS'], ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Characteristics of and Public Health Responses to ...\" with entities \"[[54, 65, 'CORONAVIRUS'], [74, 78, 'DATE'], [91, 9...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n",
      "/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages/spacy/training/iob_utils.py:141: UserWarning: [W030] Some entities could not be aligned in the text \"Systematic Comparison of Two Animal-to-Human Trans...\" with entities \"[[25, 28, 'CARDINAL'], [39, 44, 'ORGANISM'], [63, ...\". Use `spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)` to check the alignment. Misaligned entities ('-') will be ignored during training.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 59095.16835559813}\n",
      "Starting Iteartion 1\n",
      "{'ner': 1464.2317753165014}\n",
      "{'ner': 3926.526278670007}\n",
      "{'ner': 5307.26445194243}\n",
      "{'ner': 7525.158976834862}\n",
      "{'ner': 10368.724107396434}\n",
      "{'ner': 13446.688804704749}\n",
      "{'ner': 15343.567177075354}\n",
      "{'ner': 18007.50850562977}\n",
      "{'ner': 19634.381068281808}\n",
      "{'ner': 20746.66546955057}\n",
      "{'ner': 23062.484924030243}\n",
      "{'ner': 26384.272243709856}\n",
      "{'ner': 27509.98356681838}\n",
      "Starting Iteartion 2\n",
      "{'ner': 1955.5995448523572}\n",
      "{'ner': 2713.817122596066}\n",
      "{'ner': 5768.568517881086}\n",
      "{'ner': 7016.207946509701}\n",
      "{'ner': 8800.892237367236}\n",
      "{'ner': 11313.92742532388}\n",
      "{'ner': 12805.573064126316}\n",
      "{'ner': 15406.55326657214}\n",
      "{'ner': 17286.479773097617}\n",
      "{'ner': 19248.295522696928}\n",
      "{'ner': 20851.86093958991}\n",
      "{'ner': 22502.36461211864}\n",
      "{'ner': 22893.336593134798}\n",
      "Starting Iteartion 3\n",
      "{'ner': 2196.9034129840124}\n",
      "{'ner': 3433.003729358664}\n",
      "{'ner': 4981.379435745667}\n",
      "{'ner': 6256.16176355057}\n",
      "{'ner': 8279.528388292436}\n",
      "{'ner': 10419.48322569381}\n",
      "{'ner': 11684.220350765045}\n",
      "{'ner': 13352.125108734313}\n",
      "{'ner': 14715.047168163377}\n",
      "{'ner': 16345.227886480716}\n",
      "{'ner': 18345.568289104725}\n",
      "{'ner': 19317.92675830236}\n",
      "{'ner': 20862.929971221485}\n",
      "Starting Iteartion 4\n",
      "{'ner': 743.84925642544}\n",
      "{'ner': 1801.2186550968263}\n",
      "{'ner': 3739.0950536140235}\n",
      "{'ner': 4698.948134419952}\n",
      "{'ner': 5497.443236564193}\n",
      "{'ner': 7065.9374727984205}\n",
      "{'ner': 8319.140983184694}\n",
      "{'ner': 10604.822196236228}\n",
      "{'ner': 12805.138104436272}\n",
      "{'ner': 14449.213118401241}\n",
      "{'ner': 15714.05294834275}\n",
      "{'ner': 18660.87492134281}\n",
      "{'ner': 19188.230008714672}\n",
      "Starting Iteartion 5\n",
      "{'ner': 1441.0140976386797}\n",
      "{'ner': 3321.2013332647007}\n",
      "{'ner': 4451.968701565451}\n",
      "{'ner': 5237.845804553481}\n",
      "{'ner': 6157.177047726494}\n",
      "{'ner': 8285.120258533065}\n",
      "{'ner': 9180.596062557881}\n",
      "{'ner': 10501.35916064655}\n",
      "{'ner': 12657.33542235214}\n",
      "{'ner': 14634.215904149662}\n",
      "{'ner': 16513.6401439423}\n",
      "{'ner': 17561.684003575283}\n",
      "{'ner': 17767.219371150895}\n",
      "Starting Iteartion 6\n",
      "{'ner': 972.5799039106118}\n",
      "{'ner': 2103.05544084447}\n",
      "{'ner': 3696.086184458539}\n",
      "{'ner': 5787.546547593918}\n",
      "{'ner': 7286.180826670289}\n",
      "{'ner': 8371.241429722751}\n",
      "{'ner': 9384.58601011367}\n",
      "{'ner': 10512.492909230341}\n",
      "{'ner': 11462.026397429907}\n",
      "{'ner': 13101.047982363581}\n",
      "{'ner': 15250.330286035198}\n",
      "{'ner': 16561.756791996893}\n",
      "{'ner': 16886.768890307205}\n",
      "Starting Iteartion 7\n",
      "{'ner': 1237.8997791625902}\n",
      "{'ner': 3744.9708073784304}\n",
      "{'ner': 4642.197428021768}\n",
      "{'ner': 5959.42180137126}\n",
      "{'ner': 7365.024605630919}\n",
      "{'ner': 8473.807616547421}\n",
      "{'ner': 10045.924922405931}\n",
      "{'ner': 11218.167549059055}\n",
      "{'ner': 12623.685149732051}\n",
      "{'ner': 14139.077974359025}\n",
      "{'ner': 15218.77698482684}\n",
      "{'ner': 15973.47499484481}\n",
      "{'ner': 16879.902083595705}\n",
      "Starting Iteartion 8\n",
      "{'ner': 932.5836309023194}\n",
      "{'ner': 2377.1742376108305}\n",
      "{'ner': 2914.413019749409}\n",
      "{'ner': 3813.363234432598}\n",
      "{'ner': 5042.165757022538}\n",
      "{'ner': 7287.808874116526}\n",
      "{'ner': 8673.69281602614}\n",
      "{'ner': 9722.79476254247}\n",
      "{'ner': 11200.164988355125}\n",
      "{'ner': 12812.637642239737}\n",
      "{'ner': 13845.222391315192}\n",
      "{'ner': 14527.311202371302}\n",
      "{'ner': 16044.392833043616}\n",
      "Starting Iteartion 9\n",
      "{'ner': 881.5108668006269}\n",
      "{'ner': 1666.6432842572358}\n",
      "{'ner': 2320.041017924979}\n",
      "{'ner': 3533.0208001962424}\n",
      "{'ner': 4060.1866726762178}\n",
      "{'ner': 5967.250472357982}\n",
      "{'ner': 6962.037619147306}\n",
      "{'ner': 7776.919594203555}\n",
      "{'ner': 9947.079213349753}\n",
      "{'ner': 11577.569008964076}\n",
      "{'ner': 12789.15683599056}\n",
      "{'ner': 14405.507317699208}\n",
      "{'ner': 15336.267238975435}\n",
      "Starting Iteartion 10\n",
      "{'ner': 538.3845874827462}\n",
      "{'ner': 1116.8351028738514}\n",
      "{'ner': 2223.844096828617}\n",
      "{'ner': 3638.9843237602418}\n",
      "{'ner': 4427.730068599174}\n",
      "{'ner': 6045.833135186123}\n",
      "{'ner': 7465.857266197985}\n",
      "{'ner': 8497.437219553854}\n",
      "{'ner': 10156.777646769888}\n",
      "{'ner': 10998.418943630084}\n",
      "{'ner': 13017.052881399079}\n",
      "{'ner': 14217.854520612436}\n",
      "{'ner': 14757.902496620483}\n",
      "Starting Iteartion 11\n",
      "{'ner': 1867.357595196044}\n",
      "{'ner': 2831.910992944125}\n",
      "{'ner': 4688.831305850293}\n",
      "{'ner': 5314.173183808408}\n",
      "{'ner': 6783.901175807248}\n",
      "{'ner': 8496.77507873296}\n",
      "{'ner': 9307.154089066184}\n",
      "{'ner': 10114.161714017704}\n",
      "{'ner': 10938.666193711919}\n",
      "{'ner': 11810.629891287166}\n",
      "{'ner': 12998.445029176039}\n",
      "{'ner': 14052.026253948914}\n",
      "{'ner': 14325.21732025758}\n",
      "Starting Iteartion 12\n",
      "{'ner': 2133.389297001473}\n",
      "{'ner': 2848.4391290644257}\n",
      "{'ner': 3852.642553054835}\n",
      "{'ner': 4933.507824408387}\n",
      "{'ner': 6284.800585834422}\n",
      "{'ner': 7606.656822876333}\n",
      "{'ner': 8907.174696074326}\n",
      "{'ner': 9649.450214241138}\n",
      "{'ner': 10778.62188844502}\n",
      "{'ner': 11657.13326243493}\n",
      "{'ner': 12665.916992335198}\n",
      "{'ner': 13694.753979574652}\n",
      "{'ner': 13950.628461190188}\n",
      "Starting Iteartion 13\n",
      "{'ner': 867.8076463143273}\n",
      "{'ner': 1472.066909132233}\n",
      "{'ner': 3392.3192438754427}\n",
      "{'ner': 3985.3349169787116}\n",
      "{'ner': 4821.461994354601}\n",
      "{'ner': 6299.259648090025}\n",
      "{'ner': 6799.65352085939}\n",
      "{'ner': 8855.730143539431}\n",
      "{'ner': 9592.422013196268}\n",
      "{'ner': 10426.020321705031}\n",
      "{'ner': 11623.022612047349}\n",
      "{'ner': 12726.860703153125}\n",
      "{'ner': 13369.752191952683}\n",
      "Starting Iteartion 14\n",
      "{'ner': 877.7526772138449}\n",
      "{'ner': 3043.7515977360213}\n",
      "{'ner': 4590.929063734913}\n",
      "{'ner': 5142.515006282131}\n",
      "{'ner': 6203.537555787776}\n",
      "{'ner': 6729.843736224329}\n",
      "{'ner': 8084.393948729158}\n",
      "{'ner': 8769.298541644774}\n",
      "{'ner': 9559.536111758158}\n",
      "{'ner': 11132.926968090156}\n",
      "{'ner': 12417.02202746052}\n",
      "{'ner': 13350.542817545462}\n",
      "{'ner': 13649.728139662968}\n",
      "Starting Iteartion 15\n",
      "{'ner': 799.9277618498159}\n",
      "{'ner': 1271.0410870038309}\n",
      "{'ner': 2797.6055066209437}\n",
      "{'ner': 4614.082229170288}\n",
      "{'ner': 5672.517208603866}\n",
      "{'ner': 6567.610071745414}\n",
      "{'ner': 7367.993194173215}\n",
      "{'ner': 9085.203804791843}\n",
      "{'ner': 9947.691432863336}\n",
      "{'ner': 10519.796367736677}\n",
      "{'ner': 10919.31476784792}\n",
      "{'ner': 12384.473133463865}\n",
      "{'ner': 12836.946044400236}\n",
      "Starting Iteartion 16\n",
      "{'ner': 870.6583131051185}\n",
      "{'ner': 1879.7427198590694}\n",
      "{'ner': 2283.0010002167833}\n",
      "{'ner': 3492.0466737641163}\n",
      "{'ner': 4132.237504005258}\n",
      "{'ner': 4778.857152345423}\n",
      "{'ner': 6103.973078917271}\n",
      "{'ner': 7066.411359666503}\n",
      "{'ner': 7592.842705503157}\n",
      "{'ner': 8816.87279491377}\n",
      "{'ner': 10657.588884180695}\n",
      "{'ner': 11837.477701614302}\n",
      "{'ner': 12545.931758567931}\n",
      "Starting Iteartion 17\n",
      "{'ner': 1135.0812629218754}\n",
      "{'ner': 2209.47600168246}\n",
      "{'ner': 3425.11470530911}\n",
      "{'ner': 4147.909516148261}\n",
      "{'ner': 5117.569355713364}\n",
      "{'ner': 5884.063678279822}\n",
      "{'ner': 7282.53287386013}\n",
      "{'ner': 8436.002938795278}\n",
      "{'ner': 9772.467881929868}\n",
      "{'ner': 10603.963744406696}\n",
      "{'ner': 11334.6337747695}\n",
      "{'ner': 12085.305475208606}\n",
      "{'ner': 12249.163591763398}\n",
      "Starting Iteartion 18\n",
      "{'ner': 1857.3932458149886}\n",
      "{'ner': 2852.9611186804864}\n",
      "{'ner': 3819.6745396699}\n",
      "{'ner': 4453.9596417547655}\n",
      "{'ner': 5020.015132189287}\n",
      "{'ner': 5424.809341726565}\n",
      "{'ner': 6678.928456684978}\n",
      "{'ner': 7456.624248308179}\n",
      "{'ner': 8670.380688948357}\n",
      "{'ner': 9978.376461797454}\n",
      "{'ner': 10579.676592330856}\n",
      "{'ner': 11276.77200124184}\n",
      "{'ner': 11856.149046027844}\n",
      "Starting Iteartion 19\n",
      "{'ner': 1206.6886014402628}\n",
      "{'ner': 1870.9140151669228}\n",
      "{'ner': 2852.7163227671813}\n",
      "{'ner': 4139.232901176245}\n",
      "{'ner': 4472.949582717342}\n",
      "{'ner': 5236.498525132891}\n",
      "{'ner': 7066.735422264001}\n",
      "{'ner': 8080.296625061423}\n",
      "{'ner': 9002.783058781471}\n",
      "{'ner': 9996.58127995216}\n",
      "{'ner': 10647.53387935128}\n",
      "{'ner': 10900.043795416177}\n",
      "{'ner': 11472.842261303007}\n",
      "Starting Iteartion 20\n",
      "{'ner': 751.1321467873177}\n",
      "{'ner': 1571.43809887859}\n",
      "{'ner': 2181.466955465634}\n",
      "{'ner': 2631.164326943906}\n",
      "{'ner': 3957.1655821167296}\n",
      "{'ner': 4625.605865907185}\n",
      "{'ner': 5632.209981130918}\n",
      "{'ner': 6590.495629807707}\n",
      "{'ner': 7248.4910963551365}\n",
      "{'ner': 8258.208455547656}\n",
      "{'ner': 9863.919735614574}\n",
      "{'ner': 10855.630373981865}\n",
      "{'ner': 11635.417619761361}\n",
      "Starting Iteartion 21\n",
      "{'ner': 651.6070352701355}\n",
      "{'ner': 1119.6824714893557}\n",
      "{'ner': 2110.599608610736}\n",
      "{'ner': 2767.225770890019}\n",
      "{'ner': 3575.5967636078954}\n",
      "{'ner': 4917.23045456743}\n",
      "{'ner': 5755.640779573052}\n",
      "{'ner': 6536.228403780986}\n",
      "{'ner': 7777.815989912537}\n",
      "{'ner': 9129.97273666045}\n",
      "{'ner': 9861.892172907184}\n",
      "{'ner': 10239.533427207256}\n",
      "{'ner': 10939.711294594592}\n",
      "Starting Iteartion 22\n",
      "{'ner': 786.5051872465516}\n",
      "{'ner': 2180.0380378852574}\n",
      "{'ner': 2924.9980036281054}\n",
      "{'ner': 3815.5584268117464}\n",
      "{'ner': 4474.590187153207}\n",
      "{'ner': 5200.019572436626}\n",
      "{'ner': 5969.661219147543}\n",
      "{'ner': 6623.838771475899}\n",
      "{'ner': 7143.0536197042375}\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ner': 8759.98189884377}\n",
      "{'ner': 9566.112985489008}\n",
      "{'ner': 10119.663819260297}\n",
      "{'ner': 10919.739817713706}\n",
      "Starting Iteartion 23\n",
      "{'ner': 578.6424271857949}\n",
      "{'ner': 1903.8992417254792}\n",
      "{'ner': 3063.7649992321103}\n",
      "{'ner': 3521.4505813675964}\n",
      "{'ner': 4032.7831067899588}\n",
      "{'ner': 4838.559844881776}\n",
      "{'ner': 5242.91179399086}\n",
      "{'ner': 5966.900632793173}\n",
      "{'ner': 6979.12883648026}\n",
      "{'ner': 8161.646794267488}\n",
      "{'ner': 9592.398502957107}\n",
      "{'ner': 10328.294114647411}\n",
      "{'ner': 10866.242697382017}\n",
      "Starting Iteartion 24\n",
      "{'ner': 977.7750274397106}\n",
      "{'ner': 1314.934588115287}\n",
      "{'ner': 2952.7215122090165}\n",
      "{'ner': 3981.5700330990317}\n",
      "{'ner': 4532.105265374785}\n",
      "{'ner': 5257.50709138594}\n",
      "{'ner': 5990.107471090278}\n",
      "{'ner': 7191.396011510573}\n",
      "{'ner': 7884.648805917493}\n",
      "{'ner': 9140.871291973006}\n",
      "{'ner': 9593.956055715085}\n",
      "{'ner': 10333.616323602146}\n",
      "{'ner': 10785.04537390011}\n",
      "Starting Iteartion 25\n",
      "{'ner': 935.0643518977452}\n",
      "{'ner': 1729.6301536206029}\n",
      "{'ner': 2279.214313302755}\n",
      "{'ner': 3080.66552365399}\n",
      "{'ner': 3857.660214018629}\n",
      "{'ner': 5089.286704748704}\n",
      "{'ner': 5948.384879436292}\n",
      "{'ner': 7047.762372856436}\n",
      "{'ner': 7544.721294901965}\n",
      "{'ner': 8989.996392321376}\n",
      "{'ner': 9501.899294281246}\n",
      "{'ner': 10292.232163795463}\n",
      "{'ner': 10490.273884370199}\n",
      "Starting Iteartion 26\n",
      "{'ner': 1038.9677898392397}\n",
      "{'ner': 1542.0552765825364}\n",
      "{'ner': 2470.457638216074}\n",
      "{'ner': 3614.094196602112}\n",
      "{'ner': 4299.71788788577}\n",
      "{'ner': 4793.659663530023}\n",
      "{'ner': 5578.497159506861}\n",
      "{'ner': 5958.732577104222}\n",
      "{'ner': 6600.5086446713885}\n",
      "{'ner': 7898.306207652024}\n",
      "{'ner': 9031.387121291182}\n",
      "{'ner': 10048.650962879414}\n",
      "{'ner': 10346.645026591143}\n",
      "Starting Iteartion 27\n",
      "{'ner': 403.8805427577628}\n",
      "{'ner': 1021.2877963375055}\n",
      "{'ner': 1576.6677957196748}\n",
      "{'ner': 2300.1116516621573}\n",
      "{'ner': 2970.1612032779585}\n",
      "{'ner': 3424.5956447685758}\n",
      "{'ner': 4099.116201323822}\n",
      "{'ner': 5075.5719978447}\n",
      "{'ner': 6849.646566631627}\n",
      "{'ner': 7985.866822355727}\n",
      "{'ner': 8936.024372681153}\n",
      "{'ner': 9858.599977892118}\n",
      "{'ner': 9978.891365652982}\n",
      "Starting Iteartion 28\n",
      "{'ner': 763.9627623925431}\n",
      "{'ner': 1465.36864644149}\n",
      "{'ner': 2047.1524628675675}\n",
      "{'ner': 2695.060173538947}\n",
      "{'ner': 3539.733589244132}\n",
      "{'ner': 4334.995686145998}\n",
      "{'ner': 5750.8557505879635}\n",
      "{'ner': 6763.9442074960225}\n",
      "{'ner': 7150.316542317273}\n",
      "{'ner': 7991.352863255222}\n",
      "{'ner': 8842.816205593135}\n",
      "{'ner': 9917.442036533856}\n",
      "{'ner': 9996.957095614254}\n",
      "Starting Iteartion 29\n",
      "{'ner': 1268.7299617740698}\n",
      "{'ner': 2112.467363214283}\n",
      "{'ner': 2423.51496283127}\n",
      "{'ner': 2824.0066355131266}\n",
      "{'ner': 3890.41957185755}\n",
      "{'ner': 4697.34498653471}\n",
      "{'ner': 5207.8052775787155}\n",
      "{'ner': 6230.507961806521}\n",
      "{'ner': 6764.547809905189}\n",
      "{'ner': 7296.552559762688}\n",
      "{'ner': 8484.50749956357}\n",
      "{'ner': 9485.911210806009}\n",
      "{'ner': 9827.413473527597}\n"
     ]
    }
   ],
   "source": [
    "nlp = train_spacy(TRAIN[:100], 30)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "spacy.training.offsets_to_biluo_tags(nlp.make_doc(text), entities)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy import displacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc = nlp(TRAIN[0][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Angiotensin-converting enzyme 2 (ACE2) as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": molecular mechanisms and potential therapeutic target  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " has been sequenced [3] . A phylogenetic analysis [3, 4] found a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">WILDLIFE</span>\n",
       "</mark>\n",
       " origin for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       ". There is a diversity of possible \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intermediate hosts\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       ", including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pangolins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">WILDLIFE</span>\n",
       "</mark>\n",
       ", but not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " and rats [5] . There are many similarities of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " with the original \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-CoV. Using computer modeling, \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Xu et al\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". [6] found that the spike proteins of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " have almost identical 3-D structures in the receptor-binding domain that maintains van der Waals forces. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-CoV \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a strong binding affinity to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", based on biochemical interaction studies and crystal structure analysis [7] . \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " spike proteins share 76.5% identity in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequences [6] and, importantly, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " spike proteins have a high degree of homology [6, 7] . \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wan et al\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". [4] reported that residue \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    394\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glutamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " receptor-binding domain (RBD), corresponding to residue \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    479\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       ", can be recognized by the critical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lysine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 31 on the human ACE2 receptor [8] . Further analysis even suggested that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " recognizes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " more efficiently than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " increasing the ability of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " to transmit from person to person [4] . Thus, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was predicted to also have a strong binding affinity to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ". This similarity with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " is critical because ACE2 is a functional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in vitro [9] and in \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vivo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " [10] . It is required for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    host cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " entry and subsequent viral replication. Overexpression of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " enhanced disease severity in a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " model of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " infection, demonstrating that viral entry into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " is a critical step [11] ; injecting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " spike into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " worsened lung injury. Critically, this injury was attenuated by blocking the renin-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " pathway and depended on ACE2 expression [12] . Thus, for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " pathogenesis, ACE2 is not only the entry receptor of the virus but also protects from lung injury. We therefore previously suggested that in contrast to most other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronaviruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " became highly lethal because the virus deregulates a lung protective pathway [10, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Zhou et al\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". [13] demonstrated that overexpressing ACE2 from different species in HeLa cells with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pig\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LIVESTOCK</span>\n",
       "</mark>\n",
       " ACE2, civet ACE2 (but not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mouse ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       ") allowed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " infection and replication, thereby directly showing that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " uses ACE2 as a cellular entry receptor. They further demonstrated that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " does not use other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronavirus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    receptors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aminopeptidase\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " N and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dipeptidyl peptidase 4 [13\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "] . In \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    summary\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " directly binds with the host cell surface ACE2 receptor facilitating virus entry and replication. A key question is why the lung appears to be the most vulnerable target organ. \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    One\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " reason is that the vast surface area of the lung makes the lung highly susceptible to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inhaled viruses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but there is also a biological factor. Using normal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lung tissue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " from \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eight\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " adult donors, Zhao et al. [14] demonstrated that 83% of ACE2-expressing cells were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alveolar epithelial\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " type II cells (AECII), suggesting that these \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " can serve as a reservoir for viral invasion. In addition, gene ontology enrichment analysis showed that the ACE2-expressing AECII have high levels of multiple viral process-related genes, including regulatory genes for viral processes, viral life cycle, viral assembly, and viral genome replication [14] , suggesting that the ACE2-expressing AECII facilitate coronaviral replication in the lung. Expression of the ACE2 receptor is also found in many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    extrapulmonary tissues\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       " including heart, kidney, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endothelium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TISSUE</span>\n",
       "</mark>\n",
       ", and intestine [15] [16] [17] [18] [19] . Importantly, ACE2 is highly expressed on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    luminal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " surface of intestinal epithelial cells, functioning as a co-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for nutrient uptake, in particular for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " resorption from food [20] . We therefore predict that the intestine might also be a major entry site for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and that the infection might have been initiated by eating food from the Wuhan market, the putative site of the outbreak. Whether \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " can indeed infect the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gut epithelium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has important implications for fecal-oral transmission and containment of viral spread. ACE2 tissue distribution in other organs could explain the multi-organ dysfunction observed in patients [21] [22] [23] . Of note, however, according to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Centers for Disease Control\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Prevention [24], whether a person can get \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COVID-19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " by touching surfaces or objects that have virus on them and then touching mucus membranes is yet to be confirmed. There are several potential therapeutic approaches (Fig. 1) . Development of a spike1 subunit protein-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    based vaccine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may rely on the fact that ACE2 is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cell lines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " that facilitate viral replication in the presence of ACE2 may be most efficient in large-scale \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vaccine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " production. 2. Inhibition of transmembrane \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serine 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (TMPRSS2) activity. Hoffman et al. [25] recently demonstrated that initial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " priming by transmembrane \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serine 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (TMPRSS2) is essential for entry and viral spread of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " through interaction with the ACE2 receptor [26, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    27\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . The serine protease \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    camostat mesylate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", approved in \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Japan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " to treat unrelated diseases, has been shown to block TMPRSS2 activity [28, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    29\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] and is thus an interesting candidate. The interaction sites between ACE2 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " have been identified at the atomic level and from studies to date should also hold true for interactions between ACE2 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       ". Thus, one could target this interaction site with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    antibodies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or small molecules. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kuba et al\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". [10] demonstrated in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " downregulates ACE2 protein (but not ACE) by binding its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", contributing to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    severe lung\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " injury. This suggests that excessive ACE2 may competitively bind with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " not only to neutralize the virus but also rescue \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cellular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " ACE2 activity which negatively regulates the renin-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system (RAS) to protect the lung from injury [12, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    30\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . Indeed, enhanced ACE activity and decreased ACE2 availability contribute to lung injury during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "-and ventilator-induced lung injury [12, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    31\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    32\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . Thus, treatment with a soluble form of ACE2 itself may exert dual functions: (1) slow viral entry into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " and hence viral spread [7, 9] and (2) protect the lung from injury [10, \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    31\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    32\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . Notably, a recombinant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ACE2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORGANISM</span>\n",
       "</mark>\n",
       " (rhACE2; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    APN01\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", GSK2586881) has been found to be safe, with no negative hemodynamic effects in healthy volunteers and in a small cohort of patients with ARDS [\n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    33] [34] [35\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "] . The administration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    APN01\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " rapidly decreased levels of its proteolytic target \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peptide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", with a trend to lower plasma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IL-6\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentrations. Our previous work on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " pathogenesis makes ACE2 a rational and scientifically validated therapeutic target for the current \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COVID-19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " pandemic. The availability of recombinant ACE2 was the impetus to assemble a multinational team of intensivists, scientists, and biotech to rapidly initiate a pilot trial of rhACE2 in patients with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COVID-19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " (Clinicaltrials.gov #\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NCT04287686\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ").  Josef Penninger is the founder and a shareholder of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Apeiron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the company that makes rhACE2. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arthur Slutsky\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " has been a paid consultant for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Apeiron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". No other conflicts of interested have been reported. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    International License\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    third\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    line\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    http://creat iveco mmons\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " .org/licen ses/by-nc/4.0/. Potential approaches to address ACE2-mediated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COVID-19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " following \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " infection. The finding that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " use the ACE2 receptor for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " entry has important implications for understanding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " transmissibility and pathogenesis. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CoV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and likely \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " lead to downregulation of the ACE2 receptor, but not ACE, through binding of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with ACE2. This leads to viral entry and replication, as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    severe lung\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " injury. Potential therapeutic approaches include a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    based vaccine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; a transmembrane \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serine 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (TMPRSS2) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to block the priming of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spike protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; blocking the surface ACE2 receptor by using anti-ACE2 antibody or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peptides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; and a soluble form of ACE2 which should slow viral entry into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CELL</span>\n",
       "</mark>\n",
       " through competitively binding with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SARS-CoV-2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CORONAVIRUS</span>\n",
       "</mark>\n",
       " and hence decrease viral spread as well as protecting the lung from injury through its unique enzymatic function. MasR-mitochondrial assembly receptor, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AT1R\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-Ang II type 1 receptor </div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "displacy_image = displacy.render(doc, jupyter=True,style='ent')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1001"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(TRAIN)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
